欢迎进入上海起发实验试剂有限公司!
产品展示
首页 > 产品展示 > > Abcam > Abcam生化试剂65折*

Abcam生化试剂65折*

描述:Abcam,Abcam*,Abcam生化试剂*,Abcam试剂,Abcam*,Abcam现货

更新时间:2016-12-22
访问次数:1726
厂商性质:代理商
详情介绍

Abcam,Abcam*,Abcam生化试剂*,Abcam试剂,Abcam*,Abcam现货

Abcam公司是世界有名的抗体王国,以优质、齐全的产品、完善的网络支持功能和强大的队伍得到客户的认可和赞誉。并在2004年获得了对于生物界公司*的英女王奖,拥有很好的度和口碑。产品具有以下特点:

Abcam 提供一系列受体配体、离子通道调节剂、酶和信号传导工具。 
所有这些产品均具有*的纯度和非凡的品质。

  • 受体激动剂和拮抗剂
  • 离子通道调节剂
  • 酶调节剂
  • 信号传导工具
  • 新型Rhodadyn
  • GPCR 荧光工具
  • 笼形蛋白抑制剂
  • Just add water 系列  

 

产品具体订购信息如下,*:

 

货号品名描述规格价格CAS 号
AB118162NECA Fluorescent ligand (Red)Fluorescent non-selective adenosine agonist50ug2831774199-07-4
AB118162NECA Fluorescent ligand (Red)Fluorescent non-selective adenosine agonist100ug4607774199-07-4
AB118163XAC Fluorescent ligand (Red)Fluorescent non-selective adenosine antagonist50ug2831690267-56-5
AB118163XAC Fluorescent ligand (Red)Fluorescent non-selective adenosine antagonist100ug4607690267-56-5
AB118164XAC Fluorescent ligandFluorescent A3 antagonist50ug2831 
AB118164XAC Fluorescent ligandFluorescent A3 antagonist100ug4607 
AB118165Salbutamol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor agonist50ug2831 
AB118165Salbutamol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor agonist100ug4607 
AB118167Alprenolol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor antagonist50ug2831 
AB118167Alprenolol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor antagonist100ug4607 
AB118168Propranolol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor antagonist50ug2831 
AB118168Propranolol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor antagonist100ug4607 
AB118169(S)-Propranolol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor antagonist50ug2831 
AB118169(S)-Propranolol Fluorescent ligand (Red)Fluorescent beta2 adrenoceptor antagonist100ug4607 
AB118170Pindolol Fluorescent ligand (Red)Fluorescent beta2 antagonist50ug2831 
AB118170Pindolol Fluorescent ligand (Red)Fluorescent beta2 antagonist100ug4607 
AB118171(S)-Carazolol Fluorescent ligand (Red)Fluorescent beta3 adrenoceptor agonist50ug2831 
AB118171(S)-Carazolol Fluorescent ligand (Red)Fluorescent beta3 adrenoceptor agonist100ug4607 
AB118172SKF83566 Fluorescent ligand (Red)Fluorescent D1 antagonist50ug2831 
AB118172SKF83566 Fluorescent ligand (Red)Fluorescent D1 antagonist100ug4607 
AB118173CGP-54626A Fluorescent ligand (Red)Fluorescent GABAB antagonist50ug2831 
AB118173CGP-54626A Fluorescent ligand (Red)Fluorescent GABAB antagonist100ug4607 
AB118174Mepyramine Fluorescent ligand (Red)Fluorescent H1 antagonist50ug2831 
AB118174Mepyramine Fluorescent ligand (Red)Fluorescent H1 antagonist100ug4607 
AB118175Aminopotentidine Fluorescent ligand (Red)Fluorescent H2 antagonist50ug2831 
AB118175Aminopotentidine Fluorescent ligand (Red)Fluorescent H2 antagonist100ug4607 
AB118176Pirenzepine Fluorescent ligand (Red)Fluorescent M3 antagonist50ug2831 
AB118176Pirenzepine Fluorescent ligand (Red)Fluorescent M3 antagonist100ug4607 
AB118177NAN-190 Fluorescent ligand (Red)Fluorescent 5-HT1A antagonist50ug2831 
AB118177NAN-190 Fluorescent ligand (Red)Fluorescent 5-HT1A antagonist100ug4607 
AB118649Clobenpropit Fluorescent ligand (Red)Fluorescent H3 antagonist50ug2831 
AB118649Clobenpropit Fluorescent ligand (Red)Fluorescent H3 antagonist100ug4607 
AB118650ZM549865 Fluorescent ligand (Red)Fluorescent 5-HT1B antagonist50ug2831 
AB118650ZM549865 Fluorescent ligand (Red)Fluorescent 5-HT1B antagonist100ug4607 
AB120001DL-AP4Broad spectrum glutamate antagonist1g488420263-07-4
AB120001DL-AP4Broad spectrum glutamate antagonist100mg50020263-07-4
AB120002L-AP4Selective group III mGlu agonist1mg61123052-81-5
AB120002L-AP4Selective group III mGlu agonist10mg161023052-81-5
AB120002L-AP4Selective group III mGlu agonist50mg716023052-81-5
AB120003D-AP5NMDA glutamate site antagonist1mg50079055-68-8
AB120003D-AP5NMDA glutamate site antagonist10mg138879055-68-8
AB120003D-AP5NMDA glutamate site antagonist50mg616179055-68-8
AB120003D-AP5NMDA glutamate site antagonist100mg838179055-68-8
AB120004DL-AP5NMDA glutamate site antagonist10mg61176326-31-3
AB120004DL-AP5NMDA glutamate site antagonist50mg277576326-31-3
AB120005(S)-AMPAAMPA agonist5mg127783643-88-3
AB120005(S)-AMPAAMPA agonist10mg210983643-88-3
AB120005(S)-AMPAAMPA agonist50mg915883643-88-3
AB120006(S)-3,4-DCPG (UBP1109)mGlu8a agonist10mg1776201730-11-2
AB120006(S)-3,4-DCPG (UBP1109)mGlu8a agonist50mg7770201730-11-2
AB120007(S)-3,5-DHPGSelective group I mGlu agonist5mg1388162870-29-3
AB120007(S)-3,5-DHPGSelective group I mGlu agonist10mg2387162870-29-3
AB120008MPEP hydrochloridePotent, selective mGlu5 antagonist10mg111096206-92-7
AB120008MPEP hydrochloridePotent, selective mGlu5 antagonist50mg488496206-92-7
AB120009PPADSP2 purinergic receptor antagonist.10mg611149017-66-3
AB120009PPADSP2 purinergic receptor antagonist.50mg2498149017-66-3
AB120009PPADSP2 purinergic receptor antagonist.250mg9990149017-66-3
AB120010Quisqualic acidGroup I mGlu agonist. AMPA agonist.5mg99952809-07-1
AB120010Quisqualic acidGroup I mGlu agonist. AMPA agonist.10mg188752809-07-1
AB120010Quisqualic acidGroup I mGlu agonist. AMPA agonist.50mg815952809-07-1
AB120011AMN082 dihydrochloridemGlu7 agonist10mg99997075-46-2
AB120011AMN082 dihydrochloridemGlu7 agonist50mg449697075-46-2
AB120012CGP 37157Na+-Ca2+ exchange inhibitor10mg161075450-34-9
AB120012CGP 37157Na+-Ca2+ exchange inhibitor50mg699375450-34-9
AB120013(±)-Anatoxin A fumaratePotent nicotinic agonist1mg161064285-06-9
AB120014SNAPNO donor10mg61167776-06-1
AB120014SNAPNO donor50mg199867776-06-1
AB120015YM298198 hydrochloridePotent, selective mGlu1 antagonist10mg1776748758-45-4
AB120015YM298198 hydrochloridePotent, selective mGlu1 antagonist50mg7770748758-45-4
AB120016Desmethyl YM298198 hydrochlorideAnalogue of mGlu1 antagonist YM29819810mg1776299901-57-8
AB120016Desmethyl YM298198 hydrochlorideAnalogue of mGlu1 antagonist YM29819850mg7770299901-57-8
AB120017CNQXAMPA / kainate antagonist10mg1277115066-14-3
AB120017CNQXAMPA / kainate antagonist25mg2997115066-14-3
AB120017CNQXAMPA / kainate antagonist50mg5273115066-14-3
AB120018DNQXAMPA / kainate antagonist10mg5002379-57-9
AB120018DNQXAMPA / kainate antagonist50mg14992379-57-9
AB120019ClozapineAtypical antipsychotic50mg11105786-21-0
AB120019ClozapineAtypical antipsychotic500mg58835786-21-0
AB120020(R,S)-3,5-DHPGGroup I mGlu receptor agonist1mg50019641-83-9
AB120020(R,S)-3,5-DHPGGroup I mGlu receptor agonist10mg127719641-83-9
AB120020(R,S)-3,5-DHPGGroup I mGlu receptor agonist50mg566119641-83-9
AB120021Thioperamide maleatePotent, selective H3 antagonist10mg999106243-16-7
AB120021Thioperamide maleatePotent, selective H3 antagonist50mg4496106243-16-7
AB120022ODQSelective, potent inhibitor of NO-sensitive guanylyl cyclase10mg88841443-28-1
AB120022ODQSelective, potent inhibitor of NO-sensitive guanylyl cyclase50mg360841443-28-1
AB1200235,7-Dichlorokynurenic acidNMDA receptor glycine site antagonist10mg777131123-76-7
AB1200235,7-Dichlorokynurenic acidNMDA receptor glycine site antagonist50mg2997131123-76-7
AB1200235,7-Dichlorokynurenic acidNMDA receptor glycine site antagonist100mg5772131123-76-7
AB1200247-Chlorokynurenic acidNMDA receptor glycine site antagonist10mg77718000-24-3
AB1200247-Chlorokynurenic acidNMDA receptor glycine site antagonist50mg299718000-24-3
AB120025CapsazepineVR1 antagonist10mg1499138977-28-3
AB120025CapsazepineVR1 antagonist50mg5994138977-28-3
AB120026N-Desmethyl clozapine (Normethylclozapine)Clozapine metabolite. M1 agonist. D2/D3 agonist.10mg14996104-71-8
AB120026N-Desmethyl clozapine (Normethylclozapine)Clozapine metabolite. M1 agonist. D2/D3 agonist.50mg59946104-71-8
AB120027(+)-MK 801 maleate (Dizocilpine)Non-competitive NMDA antagonist10mg77777086-22-7
AB120027(+)-MK 801 maleate (Dizocilpine)Non-competitive NMDA antagonist50mg277577086-22-7
AB120028(-)-MK 801 maleateNon competitive NMDA antagonist; less active enantiomer10mg77777086-19-2
AB120028(-)-MK 801 maleateNon competitive NMDA antagonist; less active enantiomer50mg249877086-19-2
AB120029(R,S)-RolipramSelective PDE4 inhibitor10mg99961413-54-5
AB120029(R,S)-RolipramSelective PDE4 inhibitor50mg399661413-54-5
AB120030(S)-(+)-RolipramPDE4 inhibitor; less active enantiomer10mg188785416-73-5
AB120030(S)-(+)-RolipramPDE4 inhibitor; less active enantiomer50mg815985416-73-5
AB120031(R)-(-)-RolipramSelective PDE4 inhibitor10mg188785416-75-7
AB120031(R)-(-)-RolipramSelective PDE4 inhibitor50mg815985416-75-7
AB120032(+/-)-ThalidomideImmunomodulator and anticancer agent100mg61150-35-1
AB120033(R,S)-MCPGGroup I /II metabotropic glutamate antagonist10mg1388146669-29-6
AB120033(R,S)-MCPGGroup I /II metabotropic glutamate antagonist50mg5661146669-29-6
AB120034FenobamSelective, potent, orally active mGlu5 antagonist10mg111057653-26-6
AB120034FenobamSelective, potent, orally active mGlu5 antagonist50mg499557653-26-6
AB120035MTEP hydrochloridePotent, selective mGlu5 antagonist10mg13881186195-60-7
AB120035MTEP hydrochloridePotent, selective mGlu5 antagonist50mg58831186195-60-7
AB120036(S)-5-FluorowillardiinePotent, selective AMPA agonist10mg1610140187-23-1
AB120036(S)-5-FluorowillardiinePotent, selective AMPA agonist50mg6993140187-23-1
AB1200372-Chloroadenosine (CADO)Adenosine agonist10mg389146-77-0
AB1200372-Chloroadenosine (CADO)Adenosine agonist50mg999146-77-0
AB1200372-Chloroadenosine (CADO)Adenosine agonist250mg4107146-77-0
AB1200382,3 cis-Piperidine dicarboxylic acid (cis PDA)Ionotropic receptor antagonist50mg99946026-75-9
AB1200382,3 cis-Piperidine dicarboxylic acid (cis PDA)Ionotropic receptor antagonist250mg399646026-75-9
AB120039(R,S)-CHPGSelective mGlu5 agonist10mg888170846-74-9
AB120039(R,S)-CHPGSelective mGlu5 agonist50mg3996170846-74-9
AB120040(S)-WillardiineAMPA / kainate receptor agonist10mg127721416-43-3
AB120040(S)-WillardiineAMPA / kainate receptor agonist50mg566121416-43-3
AB120041Ibotenic acidExcitotoxic agonist1mg11102552-55-8
AB120041Ibotenic acidExcitotoxic agonist5mg26092552-55-8
AB120041Ibotenic acidExcitotoxic agonist25mg99902552-55-8
AB120042SR95531 (Gabazine)GABAA antagonist10mg1110104104-50-9
AB120042SR95531 (Gabazine)GABAA antagonist50mg4607104104-50-9
AB120043PHCCCSelective allosteric potentiator at mGlu4. Also group I antagonist.10mg1388 
AB120043PHCCCSelective allosteric potentiator at mGlu4. Also group I antagonist.50mg5883 
AB120044CNQX disodium saltAMPA / kainate antagonist (water soluble)1mg500115066-14-3
AB120044CNQX disodium saltAMPA / kainate antagonist (water soluble)10mg1110115066-14-3
AB120044CNQX disodium saltAMPA / kainate antagonist (water soluble)50mg5106115066-14-3
AB120045NBQXAMPA / kainate antagonist10mg1776118876-58-7
AB120045NBQXAMPA / kainate antagonist50mg7770118876-58-7
AB120046NBQX disodium saltAMPA / kainate antagonist; water soluble1mg888118876-58-7
AB120046NBQX disodium saltAMPA / kainate antagonist; water soluble10mg2109118876-58-7
AB120046NBQX disodium saltAMPA / kainate antagonist; water soluble50mg8991118876-58-7
AB120047cis-PPDAGluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist10mg1499 
AB120047cis-PPDAGluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist50mg5994 
AB120048D-SerineEndogenous NMDA receptor co-agonist1g278312-84-5
AB120048D-SerineEndogenous NMDA receptor co-agonist5g888312-84-5
AB120049L-GlutamateExcitatory neurotransmitter1g38956-86-0
AB120049L-GlutamateExcitatory neurotransmitter2500mg77756-86-0
AB120050GlycineInhibitory neurotransmitter1g50056-40-6
AB120050GlycineInhibitory neurotransmitter100mg27856-40-6
AB120051SpermineEndogenous polyamine1g61171-44-3
AB120051SpermineEndogenous polyamine100mg38971-44-3
AB120052NMDAExcitotoxic amino acid50mg7776384-92-5
AB120052NMDAExcitotoxic amino acid100mg9996384-92-5
AB120052NMDAExcitotoxic amino acid500mg33866384-92-5
AB120054TetrodotoxinNa+ channel blocker1mg17764368-28-9
AB120055Tetrodotoxin citrateNa+ channel blocker; water-soluble1mg188718660-81-6
AB120056StaurosporineStaurosporine100ug127762996-74-1
AB120056StaurosporineStaurosporine500ug499562996-74-1
AB120057Spermidine hydrochlorideEndogenous polyamine. nNOS inhibitor100mg611334-50-9
AB120058ForskolinAdenylyl cyclase activator10mg138866575-29-9
AB120058ForskolinAdenylyl cyclase activator50mg577266575-29-9
AB120058ForskolinAdenylyl cyclase activator100mg999066575-29-9
AB120059(S)-MCPGGroup I / II mGlu antagonist10mg2276150145-89-4
AB120059(S)-MCPGGroup I / II mGlu antagonist50mg9657150145-89-4
AB120060CPCCOEtSelective, non-competitive mGlu1 antagonist10mg1277179067-99-3
AB120060CPCCOEtSelective, non-competitive mGlu1 antagonist50mg5661179067-99-3
AB120061CyclothiazideAMPA receptor desensitisation inhibitor10mg7772259-96-3
AB120061CyclothiazideAMPA receptor desensitisation inhibitor50mg33862259-96-3
AB120062(S)-5-ChlorowillardiineAMPA / kainate agonist10mg1499 
AB120062(S)-5-ChlorowillardiineAMPA / kainate agonist50mg6771 
AB120063(S)-5-NitrowillardiineAMPA / kainate agonist10mg1499 
AB120063(S)-5-NitrowillardiineAMPA / kainate agonist50mg6771 
AB120064Kynurenic acidEndogenous ionotropic / nicotinic antagonist1g389492-27-3
AB120065SP600125JNK inhibitor10mg888129-56-6
AB120065SP600125JNK inhibitor50mg3386129-56-6
AB120066Dihydrokainic acidEAAT2 inhibitor1mg61152497-36-6
AB120066Dihydrokainic acidEAAT2 inhibitor10mg149952497-36-6
AB120066Dihydrokainic acidEAAT2 inhibitor50mg677152497-36-6
AB120067LY 367385mGlu1a antagonist10mg1610198419-91-9
AB120067LY 367385mGlu1a antagonist50mg6993198419-91-9
AB120068MirtazapineAntidepressant. alpha2, 5HT2, 5HT3 antagonist10mg99961337-67-5
AB120068MirtazapineAntidepressant. alpha2, 5HT2, 5HT3 antagonist50mg410761337-67-5
AB120069Paroxetine hydrochloride5HT uptake inhibitor10mg999110429-35-1
AB120069Paroxetine hydrochloride5HT uptake inhibitor50mg4496110429-35-1
AB120070Nociceptin (Orphanin FQ)ORL1 agonist1mg1277170713-75-4
AB120070Nociceptin (Orphanin FQ)ORL1 agonist5mg4107170713-75-4
AB120071ObestatinEndogenous peptide involved in feeding1mg611869705-22-6
AB120072Methyllycaconitine citrate (MLA)alpha7-nicotinic receptor antagonist5mg77721019-30-7
AB120072Methyllycaconitine citrate (MLA)alpha7-nicotinic receptor antagonist25mg277521019-30-7
AB120073(+)-TubocurarineACh receptor antagonist10mg2786989-98-6
AB120073(+)-TubocurarineACh receptor antagonist50mg5006989-98-6
AB120074Naloxone hydrochlorideOpioid antagonist100mg777357-08-4
AB120074Naloxone hydrochlorideOpioid antagonist250mg1277357-08-4
AB120075Naltrexone hydrochlorideOpioid antagonist100mg61116676-29-2
AB120075Naltrexone hydrochlorideOpioid antagonist250mg138816676-29-2
AB120076ZopicloneBenzodiazepine agonist10mg138843200-80-2
AB120076ZopicloneBenzodiazepine agonist50mg577243200-80-2
AB120077Fluoxetine hydrochloride5HT reuptake inhibitor10mg77756296-78-7
AB120077Fluoxetine hydrochloride5HT reuptake inhibitor50mg299756296-78-7
AB120078nor-Binaltorphimine (nor-BNI)Potent and selective kappa opioid receptor antagonist10mg1277105618-26-6
AB120078nor-Binaltorphimine (nor-BNI)Potent and selective kappa opioid receptor antagonist50mg5994105618-26-6
AB120079Phospho-Glycogen Synthase Peptide-2GSK substrate1mg4385 
AB120079Phospho-Glycogen Synthase Peptide-2GSK substrate500ug2387 
AB120080HaloperidolD2 antagonist100mg61152-86-8
AB120081FCCPMitochondrial oxidative phosphorylation inhibitor10mg999370-86-5
AB120081FCCPMitochondrial oxidative phosphorylation inhibitor50mg3608370-86-5
AB120082SL 327MEK inhibitor1mg777305350-87-2
AB120082SL 327MEK inhibitor10mg1776305350-87-2
AB120082SL 327MEK inhibitor25mg4274305350-87-2
AB120083RyanodineCa2+ release modulator1mg161015662-33-6
AB120084Salvinorin A (Divinorin A)Potent kappa agonist1mg138883729-01-5
AB120084Salvinorin A (Divinorin A)Potent kappa agonist5mg499583729-01-5
AB120087Anandamide (ethanol solution)Endogenous cannabinoid5mg61194421-68-8
AB120087Anandamide (ethanol solution)Endogenous cannabinoid25mg277594421-68-8
AB120088AM251CB1 receptor antagonist / inverse agonist1mg500183232-66-8
AB120088AM251CB1 receptor antagonist / inverse agonist10mg1388183232-66-8
AB120088AM251CB1 receptor antagonist / inverse agonist50mg6161183232-66-8
AB120089XE-991 dihydrochloridePotent, selective KCNQ channel blocker; blocks M current10mg1110122955-42-4
AB120089XE-991 dihydrochloridePotent, selective KCNQ channel blocker; blocks M current50mg4607122955-42-4
AB120093CycloheximideProtein synthesis inhibitor1g61166-81-9
AB120093CycloheximideProtein synthesis inhibitor100mg38966-81-9
AB120094MuscimolPotent, selective GABAA agonist1mg6112763-96-4
AB120094MuscimolPotent, selective GABAA agonist5mg8882763-96-4
AB120094MuscimolPotent, selective GABAA agonist10mg13882763-96-4
AB120094MuscimolPotent, selective GABAA agonist50mg57722763-96-4
AB120095AM404Anandamide transport inhibitor10mg777198022-70-7
AB120095AM404Anandamide transport inhibitor502997198022-70-7
mg
AB120096ACEA (ethanol solution)Potent, selective CB1 agonist5mg611220556-69-4
AB120096ACEA (ethanol solution)Potent, selective CB1 agonist25mg2775220556-69-4
AB120097ACPA (Arachidonylcyclopropylamide)CB1 agonist10mg888229021-64-1
AB120097ACPA (Arachidonylcyclopropylamide)CB1 agonist50mg3608229021-64-1
AB1200982-Arachidonylglycerol (acetonitrile solution)Endogenous cannabinoid agonist5mg238753847-30-6
AB1200982-Arachidonylglycerol (acetonitrile solution)Endogenous cannabinoid agonist25mg699353847-30-6
AB120099NADA (N-Arachidonyldopamine)Endogenous CB1 / TRPV1 agonist5mg888199875-69-9
AB120099NADA (N-Arachidonyldopamine)Endogenous CB1 / TRPV1 agonist25mg3996199875-69-9
AB120100Kainic acidPrototypic kainate receptor agonist.1mg50058002-62-3
AB120100Kainic acidPrototypic kainate receptor agonist.10mg138858002-62-3
AB120100Kainic acidPrototypic kainate receptor agonist.50mg616158002-62-3
AB120101U 93631GABAA antagonist10mg1499152273-12-6
AB120101U 93631GABAA antagonist50mg6383152273-12-6
AB120102ZD7288Sino-atrial node function modulator10mg1277133059-99-1
AB120102ZD7288Sino-atrial node function modulator50mg5384133059-99-1
AB120107(+)-BicucullineGABAA antagonist50mg1776485-49-4
AB120108(-)-Bicuculline methiodideGABAA antagonist10mg61155950-07-7
AB120108(-)-Bicuculline methiodideGABAA antagonist50mg238755950-07-7
AB120109(-)-Bicuculline methobromideGABAA antagonist10mg99973604-30-5
AB120109(-)-Bicuculline methobromideGABAA antagonist50mg449673604-30-5
AB120110(-)-Bicuculline methochlorideGABAA antagonist10mg99953552-05-9
AB120110(-)-Bicuculline methochlorideGABAA antagonist50mg427453552-05-9
AB120111IfenprodilGluN2B (formerly NR2B)-preferring NMDA antagonist10mg61123210-58-4
AB120111IfenprodilGluN2B (formerly NR2B)-preferring NMDA antagonist50mg288623210-58-4
AB120112GenisteinProtein tyrosine kinase inhibitor. Anticancer agent.10mg389446-72-0
AB120112GenisteinProtein tyrosine kinase inhibitor. Anticancer agent.50mg1499446-72-0
AB120112GenisteinProtein tyrosine kinase inhibitor. Anticancer agent.100mg2775446-72-0
AB120114Cyclosporin APP2B inhibitor25mg50059865-13-3
AB120114Cyclosporin APP2B inhibitor100mg99959865-13-3
AB120114Cyclosporin APP2B inhibitor500mg260959865-13-3
AB120115CamptothecinDNA topoisomerase inhibitor50mg6117689-3-4
AB120115CamptothecinDNA topoisomerase inhibitor250mg19987689-3-4
AB120116Ionomycin Ca2+ SaltCa2+ ionophore1mg127756092-82-1
AB120116Ionomycin Ca2+ SaltCa2+ ionophore5mg499556092-82-1
AB120117QX-314 bromide (N-Ethyllidocaine bromide)Na+ channel blocker50mg61121306-56-9
AB120117QX-314 bromide (N-Ethyllidocaine bromide)Na+ channel blocker100mg99921306-56-9
AB120118QX-314 chloride (N-Ethyllidocaine chloride)Na+ channel blocker50mg111021306-56-9
AB120119N-Methyllidocaine iodide (QX-372 iodide)Anti-arrthymic10mg111029199-61-9
AB120119N-Methyllidocaine iodide (QX-372 iodide)Anti-arrthymic50mg449629199-61-9
AB120121D-CycloserineNMDA glycine site agonist50mg38968-41-7
AB120121D-CycloserineNMDA glycine site agonist250mg149968-41-7
AB1201224-Aminopyridine (4-AP)K+ channel blocker100mg500504-24-5
AB120123Aminoguanidine hydrochlorideNOS inhibitor100mg7771937-19-5
AB1201242-APBCa2+ release modulator100mg500524-95-8
AB120125Granisetron5HT3 antagonist50mg2276107007-99-8
AB120125Granisetron5HT3 antagonist250mg6882107007-99-8
AB120126QX-222Na+ channel blocker10mg50021236-55-5
AB120126QX-222Na+ channel blocker50mg199821236-55-5
AB120127CGP 37849Competitive NMDA antagonist10mg1776127910-31-0
AB120127CGP 37849Competitive NMDA antagonist50mg7770127910-31-0
AB120128CGP 39551Competitive NMDA antagonist10mg1499127910-32-1
AB120128CGP 39551Competitive NMDA antagonist50mg6383127910-32-1
AB120129Y-27632 dihydrochlorideSelective Rho kinase inhibitor1mg888146986-50-7
AB120129Y-27632 dihydrochlorideSelective Rho kinase inhibitor10mg2276146986-50-7
AB120129Y-27632 dihydrochlorideSelective Rho kinase inhibitor50mg9657146986-50-7
AB120130(R,S)-AMPAAMPA agonist10mg177674341-63-2
AB120130(R,S)-AMPAAMPA agonist50mg749374341-63-2
AB120131ICI 182,780Estrogen receptor antagonist10mg1776129453-61-8
AB120131ICI 182,780Estrogen receptor antagonist50mg7770129453-61-8
AB120132Ketanserin tartrateSelective 5HT2 antagonist.50mg88883846-83-7
AB120132Ketanserin tartrateSelective 5HT2 antagonist.250mg399683846-83-7
AB120133Citalopram5HT reuptake inhibitor25mg111059729-32-7
AB120133Citalopram5HT reuptake inhibitor100mg427459729-32-7
AB120134OndansetronSelective 5HT3 antagonist.10mg88899614-02-5
AB120134OndansetronSelective 5HT3 antagonist.50mg360899614-02-5
AB120135NifedipineL-type Ca2+ channel blocker1g50021829-25-4
AB120135NifedipineL-type Ca2+ channel blocker250mg38921829-25-4
AB120136Nomega-Nitro-L-arginine Methyl Ester hydrochloride (L-NAME)NOS inhibitor100mg61151298-62-5
AB120137NG-Monomethyl-L-arginine, monoacetate salt (L-NMMA)NOS inhibitor10mg50053308-83-1
AB120137NG-Monomethyl-L-arginine, monoacetate salt (L-NMMA)NOS inhibitor50mg210953308-83-1
AB120138NimodipineL-type Ca2+ channel blocker100mg61166085-59-4
AB120138NimodipineL-type Ca2+ channel blocker500mg260966085-59-4
AB120139NitrendipineL-type Ca2+ channel blocker100mg188739562-70-4
AB120139NitrendipineL-type Ca2+ channel blocker500mg749339562-70-4
AB120140Verapamil hydrochlorideL-type Ca2+ channel blocker1g777152-11-4
AB120141ApigeninAnticancer agent10mg389520-36-5
AB120141ApigeninAnticancer agent50mg1499520-36-5
AB120142IsradipineL-type Ca2+ channel blocker10mg99975695-93-1
AB120142IsradipineL-type Ca2+ channel blocker50mg449675695-93-1
AB120143PaclitaxelAnticancer agent10mg111033069-62-4
AB120143PaclitaxelAnticancer agent50mg410733069-62-4
AB1201444-DAMPMuscarinic receptor antagonist25mg5001952-15-4
AB1201444-DAMPMuscarinic receptor antagonist100mg17761952-15-4
AB120145Nicotinic acid (Niacin)Antidyslipidemic agent10g27859-67-6
AB120147HerkinorinNon-internalising μ opioid agonist1mg1499 
AB120148WortmanninPI3-kinase inhibitor1mg77719545-26-7
AB120148WortmanninPI3-kinase inhibitor5mg249819545-26-7
AB120149(R,S)-BaclofenGABAB agonist1g6111134-47-0
AB1201506,7-ADTN hydrobromideDopamine agonist10mg61113575-86-5
AB1201506,7-ADTN hydrobromideDopamine agonist50mg277513575-86-5
AB120151AQ-RA 741M2 antagonist10mg1388123548-16-3
AB120151AQ-RA 741M2 antagonist50mg5772123548-16-3
AB120152AF-DX 116 (Otenzepad)M2 antagonist10mg1499102394-31-0
AB120152AF-DX 116 (Otenzepad)M2 antagonist50mg5994102394-31-0
AB120153Pirenzepine dihydrochlorideM1 antagonist100mg61128797-61-7
AB120153Pirenzepine dihydrochlorideM1 antagonist500mg161028797-61-7
AB120156Tropisetron hydrochloride5-HT3 antagonist10mg1277105826-92-4
AB120156Tropisetron hydrochloride5-HT3 antagonist50mg5384105826-92-4
AB120157Reboxetine mesylateNoradrenaline reuptake inhibitor10mg138871620-89-8
AB120157Reboxetine mesylateNoradrenaline reuptake inhibitor50mg616171620-89-8
AB120158E-4031 dihydrochlorideHERG K+ channel blocker10mg1610113559-13-0
AB120158E-4031 dihydrochlorideHERG K+ channel blocker50mg6993113559-13-0
AB120159(R)-CPPPotent NMDA antagonist10mg2997126453-07-4
AB120159(R)-CPPPotent NMDA antagonist50mg13376126453-07-4
AB120160(R,S)-CPPPotent NMDA antagonist10mg1499100828-16-8
AB120160(R,S)-CPPPotent NMDA antagonist50mg6383100828-16-8
AB120161PPTSubtype selective ERalpha agonist10mg1610263717-53-9
AB120161PPTSubtype selective ERalpha agonist50mg6272263717-53-9
AB120162SB 203580p38 MAP kinase inhibitor1mg888152121-47-6
AB120162SB 203580p38 MAP kinase inhibitor10mg1887152121-47-6
AB120162SB 203580p38 MAP kinase inhibitor50mg8381152121-47-6
AB120163SB431542ALK inhibitor1mg999301836-41-9
AB120163SB431542ALK inhibitor5mg1277301836-41-9
AB120163SB431542ALK inhibitor10mg2276301836-41-9
AB1201651400WSelective iNOS inhibitor10mg1110180001-34-7
AB1201651400WSelective iNOS inhibitor50mg4884180001-34-7
AB120166DPNPotent, selective ERbeta agonist10mg11101428-67-7
AB120166DPNPotent, selective ERbeta agonist50mg51061428-67-7
AB120167CGP 35348GABAB antagonist, brain penetrant10mg1610123690-79-9
AB120167CGP 35348GABAB antagonist, brain penetrant50mg6993123690-79-9
AB120168UBP310GluK1 and GluK3 selective antagonist10mg1499 
AB120168UBP310GluK1 and GluK3 selective antagonist50mg5994 
AB120169DNQX disodium saltAMPA / kainate antagonist (water soluble)10mg611 
AB120169DNQX disodium saltAMPA / kainate antagonist (water soluble)50mg2498 
AB120170Substance PSensory neuropeptide1mg50033507-63-0
AB120170Substance PSensory neuropeptide5mg127733507-63-0
AB120171Neuropeptide Y 13-36 (porcine)NPY Y2 agonist1mg2276113662-54-7
AB120171Neuropeptide Y 13-36 (porcine)NPY Y2 agonist5mg8880113662-54-7
AB120172Galanin (1-16) (porcine, rat)N-terminal galanin fragment1mg1887 
AB120172Galanin (1-16) (porcine, rat)N-terminal galanin fragment500ug999 
AB120173LY 354740Group II mGlu agonist. Systemically active.10mg1776176199-48-7
AB120173LY 354740Group II mGlu agonist. Systemically active.50mg7770176199-48-7
AB120174Neuropeptide S (mouse)NPS receptor agonist1mg3996 
AB120175(Arg-8)-Vasopressin (AVP)Vasopressin receptor agonist1mg611113-79-1
AB120175(Arg-8)-Vasopressin (AVP)Vasopressin receptor agonist5mg2387113-79-1
AB120176SLIGRL-NH2PAR2 agonist peptide1mg777171436-38-7
AB120177TFLLR-NH2PAR1 agonist peptide1mg2387197794-83-5
AB120178BAM (8-22) (Bovine Adrenal Medulla 8-22)SNSR agonist1mg2997412961-36-5
AB120179AY-NH2PAR4 agonist peptide1mg2387352017-71-1
AB120179AY-NH2PAR4 agonist peptide5mg5661352017-71-1
AB120180VIP (Vasoactive Intestinal Peptide) (6-28)VPAC antagonist1mg227669698-54-0
AB120181Kisspeptin-13 (4-13) (human) (KiSS-1 (112-121))AXOR12 agonist1mg2775374675-21-5
AB120182SAMS peptideAMP-activated protein kinase substrate1mg1388125911-68-4
AB120182SAMS peptideAMP-activated protein kinase substrate5mg5495125911-68-4
AB120183Angiotensin II (human)Vasoconstrictor peptide5mg61168521-88-0
AB120183Angiotensin II (human)Vasoconstrictor peptide25mg149968521-88-0
AB120184Luteinizing Hormone Releasing Hormone (LHRH)Reproductive hormone5mg177633515-09-2
AB120184Luteinizing Hormone Releasing Hormone (LHRH)Reproductive hormone25mg499533515-09-2
AB120185Neurokinin ATachykinin peptide5mg188786933-74-6
AB120185Neurokinin ATachykinin peptide25mg749386933-74-6
AB120186OxytocinReproductive hormone5mg88850-56-6
AB120186OxytocinReproductive hormone25mg338650-56-6
AB120188Locustatachykinin IInsect tachykinin-related peptide1mg1610126985-97-5
AB120189alpha-MSH (alpha-Melanocyte-stimulating hormone)Endogenous melanocortin receptor agonist1mg611581-05-5
AB120189alpha-MSH (alpha-Melanocyte-stimulating hormone)Endogenous melanocortin receptor agonist5mg1998581-05-5
AB120190NKH 477 (Colforsin daropate)Water-soluble analogue of forskolin ab120058, an adenylyl cyclase activator10mg1776138605-00-2
AB120190NKH 477 (Colforsin daropate)Water-soluble analogue of forskolin ab120058, an adenylyl cyclase activator50mg7770138605-00-2
AB120191JNJ 10191584 maleate (VUF 6002)Selective H4 antagonist10mg888869497-75-6
AB120191JNJ 10191584 maleate (VUF 6002)Selective H4 antagonist50mg5384869497-75-6
AB120192DynasoreCell permeable dynamin inhibitor10mg1110304448-55-3
AB120192DynasoreCell permeable dynamin inhibitor50mg4884304448-55-3
AB120193UBP141GluN2D (formerly NR2D) antagonist, with some subunit selectivity10mg1277344768-30-5
AB120194UBP304Potent, selective GluK1 (fomerly GLUK5) receptor antagonist10mg1887 
AB120195UBP308Inactive isomer of the GluK1 (fomerly GLUK5) receptor antagonist UBP30410mg1887 
AB120196LY 379268Group II mGlu agonist. Systemically active.10mg3275191471-52-0
AB120196LY 379268Group II mGlu agonist. Systemically active.50mg14652191471-52-0
AB120199LY 341495Potent, selective group II antagonist. Group III antagonist at higher concentrations.1mg888201943-63-7
AB120199LY 341495Potent, selective group II antagonist. Group III antagonist at higher concentrations.10mg2276201943-63-7
AB120199LY 341495Potent, selective group II antagonist. Group III antagonist at higher concentrations.50mg9657201943-63-7
AB120201LY 456236mGlu1 non competitive antagonist10mg1110338738-57-1
AB120201LY 456236mGlu1 non competitive antagonist50mg4884338738-57-1
AB120202SB 216763Potent selective GSK-3 inhibitor1mg611280744-09-4
AB120202SB 216763Potent selective GSK-3 inhibitor10mg1610280744-09-4
AB120202SB 216763Potent selective GSK-3 inhibitor50mg6660280744-09-4
AB120204Oxytocin (free acid)Reproductive hormone5mg88824346-32-5
AB120205alpha-MSH (free acid)Endogenous melanocortin receptor agonist5mg227610466-28-1
AB120208Neuropeptide Y (NPY) (human, rat)Endogenous neuropeptide1mg588390880-35-6
AB120208Neuropeptide Y (NPY) (human, rat)Endogenous neuropeptide500ug299790880-35-6
AB120209CCK Octapeptide sulfatedC-terminal ocatapeptide of CCK1mg138825126-32-3
AB120210omega-Agatoxin IVACa2+ channel blocker (P and Q type)10ug1776145017-83-0
AB120210omega-Agatoxin IVACa2+ channel blocker (P and Q type)100ug5994145017-83-0
AB120211omega-Conotoxin MVIICCa2+ channel blocker (P and Q-type)100ug1998147794-23-8
AB120211omega-Conotoxin MVIICCa2+ channel blocker (P and Q-type)500ug7770147794-23-8
AB120212Orexin A (bovine, human, mouse, rat)Neuropeptide involved in feeding and sleep1mg6272205640-90-0
AB120212Orexin A (bovine, human, mouse, rat)Neuropeptide involved in feeding and sleep100ug1499205640-90-0
AB120212Orexin A (bovine, human, mouse, rat)Neuropeptide involved in feeding and sleep500ug3774205640-90-0
AB120214Exendin-4 (Exenatide)Potent GLP-1 receptor agonist1mg3608141758-74-9
AB120214Exendin-4 (Exenatide)Potent GLP-1 receptor agonist500ug1998141758-74-9
AB120215omega-Conotoxin GVIACa2+ channel blocker (N type)1mg6882106375-28-4
AB120215omega-Conotoxin GVIACa2+ channel blocker (N type)500ug3885106375-28-4
AB120218ZM 241385Potent, selective A2A antagonist10mg1388139180-30-6
AB120218ZM 241385Potent, selective A2A antagonist50mg5883139180-30-6
AB120219Gabapentinalpha2delta ligand10mg88860142-96-3
AB120219Gabapentinalpha2delta ligand50mg360860142-96-3
AB120220D4476CK1 inhibitor10mg1776301836-43-1
AB120220D4476CK1 inhibitor50mg7770301836-43-1
AB120221(R,S)-CHPG sodium saltmGlu5 agonist; water soluble10mg1110 
AB120221(R,S)-CHPG sodium saltmGlu5 agonist; water soluble50mg4496 
AB120222(S)-5-IodowillardiineGluK1 kainate agonist10mg1499140187-25-3
AB120222(S)-5-IodowillardiineGluK1 kainate agonist50mg6771140187-25-3
AB120223FK506 (Tacrolimus)Immunosuppressant10mg1110104987-11-3
AB120223FK506 (Tacrolimus)Immunosuppressant50mg4995104987-11-3
AB120224RapamycinImmunosuppressant1mg227653123-88-9
AB120224RapamycinImmunosuppressant5mg749353123-88-9
AB120225HarminePotent and selective inhibitor of DYRK1A100mg500442-51-3
AB120226Vincristine sulfate saltMicrotubule inhibitor5mg6112068-78-2
AB120226Vincristine sulfate saltMicrotubule inhibitor25mg24982068-78-2
AB120227EtoposideTopoisomerase II inhibitor25mg50033419-42-0
AB120227EtoposideTopoisomerase II inhibitor100mg111033419-42-0
AB120230Ghrelin (human)Endogenous GHS agonist1mg3608258279-04-8
AB120231Ghrelin (rat)Endogenous GHS agonist1mg3996258338-12-4
AB120232(R)-CPPene (SDZ EAA 494)Potent competitive NMDA antagonist10mg3386117414-74-1
AB1202337-NitroindazoleNOS inhibitor50mg6112942-42-9
AB120234PD 98059MEK1 inhibitor1mg500167869-21-8
AB120234PD 98059MEK1 inhibitor10mg1277167869-21-8
AB120234PD 98059MEK1 inhibitor50mg5384167869-21-8
AB120235SB 203580 hydrochloridep38 MAP kinase inhibitor; water soluble10mg2276869185-85-3
AB120236Rasagiline mesylateMAO-B inhibitor10mg500161735-79-1
AB120236Rasagiline mesylateMAO-B inhibitor50mg1277161735-79-1
AB120237Tiagabine hydrochlorideSelective GAT-1 inhibitor10mg999115103-54-3
AB120237Tiagabine hydrochlorideSelective GAT-1 inhibitor50mg3996115103-54-3
AB120238Prazosin hydrochloridealpha-adrenoceptor antagonist. Melatonin antagonist.50mg50019237-84-4
AB120238Prazosin hydrochloridealpha-adrenoceptor antagonist. Melatonin antagonist.250mg210919237-84-4
AB120239Yohimbine hydrochlorideSelective alpha2-adrenoceptor antagonist1g38965-19-0
AB120239Yohimbine hydrochlorideSelective alpha2-adrenoceptor antagonist5g138865-19-0
AB120240CaffeinePDE inhibitor. Adenosine antagonist1g2781958-8-2
AB120240CaffeinePDE inhibitor. Adenosine antagonist5g3891958-8-2
AB120241U0126Selective MKK inhibitor5mg1776109511-58-2
AB120241U0126Selective MKK inhibitor25mg7770109511-58-2
AB120242FlumazenilBenzodiazepine antagonist10mg77778755-81-4
AB120242FlumazenilBenzodiazepine antagonist50mg338678755-81-4
AB120243LY 294002PI-3 kinase inhibitor5mg1110154447-36-6
AB120243LY 294002PI-3 kinase inhibitor25mg4884154447-36-6
AB120244VU0155041PAM for mGluR410mg389 
AB120244VU0155041PAM for mGluR450mg1499 
AB120245MMPIPmGlu7 allosteric antagonist1mg611479077-02-6
AB120245MMPIPmGlu7 allosteric antagonist10mg1610479077-02-6
AB120245MMPIPmGlu7 allosteric antagonist50mg6993479077-02-6
AB120246Neuropeptide S (rat)NPS receptor agonist1mg3996412938-75-1
AB120247QuercetinAnti-oxidative flavonoid100mg5006151-25-3
AB120248VU0155041 sodium saltPAM for mGluR4 (water soluble)10mg500 
AB120248VU0155041 sodium saltPAM for mGluR4 (water soluble)50mg1776 
AB120249Memantine hydrochlorideNMDA antagonist, ion channel site50mg88841100-52-1
AB120250SKF 97541Highly potent GABAB agonist10mg1499127729-35-5
AB120250SKF 97541Highly potent GABAB agonist50mg6383127729-35-5
AB120251ACEA (Arachidonyl-2-chloroethylamide)Potent, selective CB1 agonist5mg611220556-69-4
AB120251ACEA (Arachidonyl-2-chloroethylamide)Potent, selective CB1 agonist25mg2387220556-69-4
AB120252(R,S)-MCPG sodium saltGroup I /II metabotropic glutamate antagonist; water soluble10mg1388 
AB120252(R,S)-MCPG sodium saltGroup I /II metabotropic glutamate antagonist; water soluble50mg5772 
AB120253DL-AP4 sodium saltBroad spectrum glutamate antagonist; water soluble1g5883 
AB120253DL-AP4 sodium saltBroad spectrum glutamate antagonist; water soluble100mg777 
AB1202545,7-Dichlorokynurenic acid sodium saltNMDA receptor glycine site antagonist; water soluble10mg777 
AB1202545,7-Dichlorokynurenic acid sodium saltNMDA receptor glycine site antagonist; water soluble50mg3386 
AB1202545,7-Dichlorokynurenic acid sodium saltNMDA receptor glycine site antagonist; water soluble100mg5661 
AB1202557-Chlorokynurenic acid sodium saltNMDA receptor glycine site antagonist; water soluble10mg777 
AB1202557-Chlorokynurenic acid sodium saltNMDA receptor glycine site antagonist; water soluble50mg3386 
AB120256Kynurenic acid sodium saltEndogenous ionotropic / nicotinic antagonist; water soluble1g611 
AB120256Kynurenic acid sodium saltEndogenous ionotropic / nicotinic antagonist; water soluble5g2886 
AB120257Philanthotoxin-7,4 (PhTx-74)GluA1/GluA2 (formerly GluR1/2) inhibitor1mg777401601-12-5
AB120257Philanthotoxin-7,4 (PhTx-74)GluA1/GluA2 (formerly GluR1/2) inhibitor10mg1776401601-12-5
AB120257Philanthotoxin-7,4 (PhTx-74)GluA1/GluA2 (formerly GluR1/2) inhibitor50mg7493401601-12-5
AB1202581-EBIOActivator of Ca2+-activated K+ channels and CFTR channels10mg61110045-45-1
AB1202581-EBIOActivator of Ca2+-activated K+ channels and CFTR channels50mg238710045-45-1
AB120259SNX 482R-Type Ca2+ (Cav2.3) channel blocker10ug1499203460-30-4
AB120259SNX 482R-Type Ca2+ (Cav2.3) channel blocker100ug5273203460-30-4
AB120260DiltiazemL-type Ca2+ channel antagonist1g77733286-22-5
AB120264Ruthenium redCalcium signalling inhibitor100mg77711103-72-3
AB120266DiazoxideSelective KIR6.x (ATP-sensitive K+ channel) activator100mg500364-98-7
AB120267Glibenclamide (Glyburide)K+ channel blocker100mg50010238-21-8
AB120268ApaminBlocker of small conductance Ca2+-activated K+ channels500ug177624345-16-2
AB120269CharybdotoxinK+ channel blocker10ug111095751-30-7
AB120269CharybdotoxinK+ channel blocker100ug349795751-30-7
AB120270TerfenadineK+ channel blocker. H1 antagonist.100mg161050679-08-8
AB120271DL-AP5 sodium saltNMDA glutamate site antagonist. Water soluble form.10mg611 
AB120271DL-AP5 sodium saltNMDA glutamate site antagonist. Water soluble form.50mg2775 
AB120272Riluzole (PK 26124)Neuroprotective agent. Modulates glutamate transmission.10mg3891744-22-5
AB120272Riluzole (PK 26124)Neuroprotective agent. Modulates glutamate transmission.50mg9991744-22-5
AB120275Tetraethylammonium chloride (TEA)Non-selective K+ channel blocker5g38956-34-8
AB120275Tetraethylammonium chloride (TEA)Non-selective K+ channel blocker25g50056-34-8
AB120275Tetraethylammonium chloride (TEA)Non-selective K+ channel blocker100g111056-34-8
AB120276tBuBHQ (BHQ)Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor100mg50088-58-4
AB120276tBuBHQ (BHQ)Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor500mg210988-58-4
AB120278TolbutamideK+ channel blocker100mg38964-77-7
AB120279VeratridineNa+ channel opener10mg88871-62-5
AB120279VeratridineNa+ channel opener50mg360871-62-5
AB120280SKF 96365Blocker of TRP cation channels. Inhibits capacitative Ca2+ entry.10mg1499130495-35-1
AB120280SKF 96365Blocker of TRP cation channels. Inhibits capacitative Ca2+ entry.50mg6383130495-35-1
AB120281Amiloride hydrochlorideeNaC blocker100mg5002016-88-8
AB120282A 803467Selective NaV1.8 channel blocker10mg1110944261-79-4
AB120282A 803467Selective NaV1.8 channel blocker50mg4385944261-79-4
AB120284KB-R7943NCX inhibitor. TRPC blocker.10mg1499182004-65-5
AB120284KB-R7943NCX inhibitor. TRPC blocker.50mg5994182004-65-5
AB120285S-Nitrosoglutathione (SNOG)NO donor10mg77757564-91-7
AB120285S-Nitrosoglutathione (SNOG)NO donor50mg249857564-91-7
AB120286ThapsigarginCa2+-ATPase inhibitor1mg88867526-95-8
AB120287A23187 (Calcimycin)Ca2+ ionophore10mg138852665-69-7
AB120287A23187 (Calcimycin)Ca2+ ionophore50mg399652665-69-7
AB120289TMCBSelective CK2 inhibitor10mg1110905105-89-7
AB120289TMCBSelective CK2 inhibitor50mg4496905105-89-7
AB120290Ro 25-6981 maleate saltNR2B antagonist1mg611169274-78-6
AB120290Ro 25-6981 maleate saltNR2B antagonist10mg1610169274-78-6
AB120290Ro 25-6981 maleate saltNR2B antagonist50mg6660169274-78-6
AB120292Exo-1Vesicular trafficking inhibitor10mg999461681-88-9
AB120292Exo-1Vesicular trafficking inhibitor50mg4107461681-88-9
AB120293YM 202074mGlu1 antagonist10mg1610299900-83-7
AB120293YM 202074mGlu1 antagonist50mg7493299900-83-7
AB120295NS 398COX-2 inhibitor10mg1499123653-11-2
AB120295NS 398COX-2 inhibitor50mg6383123653-11-2
AB120296Tunicamycin from Streptomyces spAntibiotic. Protein glycosylation inhibitor10mg149911089-65-9
AB120296Tunicamycin from Streptomyces spAntibiotic. Protein glycosylation inhibitor50mg616111089-65-9
AB120297Phorbol 12-myristate 13-acetate (PMA)PKC activator1mg50016561-29-8
AB120297Phorbol 12-myristate 13-acetate (PMA)PKC activator5mg177616561-29-8
AB120297Phorbol 12-myristate 13-acetate (PMA)PKC activator25mg716016561-29-8
AB120299Brefeldin AInihibitor of ADP-ribosylation factor5mg127720350-15-6
AB120299Brefeldin AInihibitor of ADP-ribosylation factor25mg549520350-15-6
AB120300Cyclopiazonic acid from Penicillium grisefulvumCa2+-ATPase inhibitor10mg127718172-33-3
AB120300Cyclopiazonic acid from Penicillium grisefulvumCa2+-ATPase inhibitor50mg510618172-33-3
AB120301Amyloid beta (1-42) (human)Predominant amyloid-beta protein fragment1mg4385107761-42-2
AB120301Amyloid beta (1-42) (human)Predominant amyloid-beta protein fragment100ug1277107761-42-2
AB120304Purvalanol APotent CDK inhibitor1mg888212844-53-6
AB120304Purvalanol APotent CDK inhibitor10mg1887212844-53-6
AB120304Purvalanol APotent CDK inhibitor50mg8381212844-53-6
AB120305Purvalanol BCDK2 inhibitor10mg1887212844-54-7
AB120305Purvalanol BCDK2 inhibitor50mg8381212844-54-7
AB120306HA-1077ROCK2 inhibitor10mg1277103745-39-7
AB120306HA-1077ROCK2 inhibitor50mg5384103745-39-7
AB120307gamma-DGG (gamma-D-glutamylglycine)Ionotropic glutamate antagonist. Low affinity AMPA antagonist.50mg12776729-55-1
AB120308PP2Src and RIP2 kinase inhibitor1mg888172889-27-9
AB120308PP2Src and RIP2 kinase inhibitor5mg1388172889-27-9
AB120308PP2Src and RIP2 kinase inhibitor10mg2276172889-27-9
AB120309UCPH-101Potent, selective EAAT1 inhibitor1mg9991118460-77-7
AB120309UCPH-101Potent, selective EAAT1 inhibitor10mg18871118460-77-7
AB120310VigabatrinIrreversible inhibitor of GABA transaminase10mg77760643-86-8
AB120310VigabatrinIrreversible inhibitor of GABA transaminase50mg288660643-86-8
AB120311EtomidateGABAA agonist10mg111033125-97-2
AB120311EtomidateGABAA agonist50mg488433125-97-2
AB120312Nipecotic acidGABA reuptake inhibitor1g111060252-41-7
AB120312Nipecotic acidGABA reuptake inhibitor5g238760252-41-7
AB120312Nipecotic acidGABA reuptake inhibitor100mg50060252-41-7
AB120314FurosemideInhibitor of the Na+/2Cl-/K+ cotransporter. Also GABAA antagonist.1g38954-31-9
AB120314FurosemideInhibitor of the Na+/2Cl-/K+ cotransporter. Also GABAA antagonist.5g149954-31-9
AB120314FurosemideInhibitor of the Na+/2Cl-/K+ cotransporter. Also GABAA antagonist.10g210954-31-9
AB120315PicrotoxinGABAA antagonist1g389124-87-8
AB120315PicrotoxinGABAA antagonist5g1610124-87-8
AB120316AniracetamAMPA receptor potentiator50mg111072432-10-1
AB120316AniracetamAMPA receptor potentiator250mg449672432-10-1
AB120317NNC 05-2090GABA uptake inhibitor10mg1776184845-43-0
AB120317NNC 05-2090GABA uptake inhibitor50mg7770184845-43-0
AB120318rac BHFFPotent, selective GABAB positive allosteric modulator10mg1277123557-91-5
AB120318rac BHFFPotent, selective GABAB positive allosteric modulator50mg5106123557-91-5
AB120325(R)-BaclofenSelective GABAB agonist. Active enantiomer.10mg77769308-37-8
AB120325(R)-BaclofenSelective GABAB agonist. Active enantiomer.50mg299769308-37-8
AB120325(R)-BaclofenSelective GABAB agonist. Active enantiomer.250mg815969308-37-8
AB120326SKF89976A hydrochlorideHighly selective GAT-1 inhibitor10mg99985375-15-1
AB120326SKF89976A hydrochlorideHighly selective GAT-1 inhibitor50mg410785375-15-1
AB120327SaclofenGABAB antagonist10mg1610125464-42-8
AB120327SaclofenGABAB antagonist50mg6993125464-42-8
AB120328EMD 386088 hydrochloridePotent 5HT6 agonist10mg127754635-62-0
AB120328EMD 386088 hydrochloridePotent 5HT6 agonist50mg510654635-62-0
AB1203293-APPA (CGP 27492)Potent, selective GABAB agonist10mg1277103680-47-3
AB1203293-APPA (CGP 27492)Potent, selective GABAB agonist50mg5106103680-47-3
AB120330CGP 52432Potent GABAB antagonist10mg1887139667-74-6
AB120330CGP 52432Potent GABAB antagonist50mg8159139667-74-6
AB120331FFN511 (Fluorescent False Neurotransmitter 511)Fluorescent false neurotransmitter; highly efficient optical tracer of dopamine1mg12771004548-96-2
AB120331FFN511 (Fluorescent False Neurotransmitter 511)Fluorescent false neurotransmitter; highly efficient optical tracer of dopamine5mg19981004548-96-2
AB120332SB 399885 hydrochloridePotent, selective 5HT6 antagonist10mg1776402713-80-8
AB120332SB 399885 hydrochloridePotent, selective 5HT6 antagonist50mg7493402713-80-8
AB120333D890Intracellular Ca2+ channel blocker10mg611 
AB120333D890Intracellular Ca2+ channel blocker50mg2498 
AB120334Propofol (ICI 35868)GABAA agonist1g7772078-54-8
AB120335A 769662AMP-activated protein kinase activator10mg1610844499-71-4
AB120335A 769662AMP-activated protein kinase activator50mg7160844499-71-4
AB120336GYKI 52466Selective non-competitive AMPA antagonist10mg1277102771-26-6
AB120336GYKI 52466Selective non-competitive AMPA antagonist50mg5384102771-26-6
AB120337CGP 55845 hydrochloridePotent, selective GABAB antagonist10mg1776149184-22-5
AB120337CGP 55845 hydrochloridePotent, selective GABAB antagonist50mg7770149184-22-5
AB120338Domoic acidKainate agonist. Neurotoxin.1mg149914277-97-5
AB120338Domoic acidKainate agonist. Neurotoxin.5mg538414277-97-5
AB120339ResiniferatoxinUltrapotent TRPV1 agonist1mg127757444-62-9
AB1203405'-IodoresiniferatoxinSelective TRPV1 antagonist. Some partial agonist activity reported.1mg3386 
AB120341H89 dihydrochlorideKinase inhibitor1mg611127243-85-0
AB120341H89 dihydrochlorideKinase inhibitor10mg1610127243-85-0
AB120341H89 dihydrochlorideKinase inhibitor50mg6993127243-85-0
AB120342Org 27569Potent CB1 receptor allosteric modulator10mg1610868273-06-7
AB120342Org 27569Potent CB1 receptor allosteric modulator50mg6660868273-06-7
AB120344Gp 1aHighly potent and selective CB2 agonist10mg1998 
AB120344Gp 1aHighly potent and selective CB2 agonist50mg8658 
AB120345PalmitoylethanolamidePotent, selective GPR55 agonist10mg611544-31-0
AB120345PalmitoylethanolamidePotent, selective GPR55 agonist50mg2775544-31-0
AB120346N-Arachidonylglycine (NAGly)T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor.5mg999179113-91-8
AB120346N-Arachidonylglycine (NAGly)T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor.25mg4107179113-91-8
AB120346N-Arachidonylglycine (NAGly)T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor.100mg9380179113-91-8
AB120349GR 1257435HT1B/1D antagonist10mg999148547-33-5
AB120350AACOCF3 (Arachidonyl trifluoromethyl ketone)Phospholipase-A2 inhibitor5mg777149301-79-1
AB120350AACOCF3 (Arachidonyl trifluoromethyl ketone)Phospholipase-A2 inhibitor25mg2997149301-79-1
AB120354Flufenamic acidNSAID. COX inhibitor, channel blocker.100mg278530-78-9
AB120355ClioquinolMetal chelator and ionophore1g2498522629-08-9
AB120355ClioquinolMetal chelator and ionophore100mg389522629-08-9
AB120356Mifepristone (RU486)Mifepristone (RU486)100mg77784371-65-3
AB120356Mifepristone (RU486)Mifepristone (RU486)500mg299784371-65-3
AB120357KaempferolPhytoestrogen. Proapoptotic agent.10mg500520-18-3
AB120357KaempferolPhytoestrogen. Proapoptotic agent.50mg777520-18-3
AB120358AICAR (Acadesine/AICA riboside)Cell-permeable activator of AMP-activated protein kinase50mg9992627-69-2
AB120358AICAR (Acadesine/AICA riboside)Cell-permeable activator of AMP-activated protein kinase250mg26092627-69-2
AB120359GABAInhibitory neurotransmitter1g3891956-12-2
AB120359GABAInhibitory neurotransmitter5g8881956-12-2
AB120361(R)-(+)-Methanandamide (ethanol solution)Stable anandamide analogue. CB1 receptor agonist.5mg611157182-49-5
AB120361(R)-(+)-Methanandamide (ethanol solution)Stable anandamide analogue. CB1 receptor agonist.25mg2109157182-49-5
AB120363CDPPBPAM for mGlu5. Active in vivo.10mg1610781652-57-1
AB120363CDPPBPAM for mGlu5. Active in vivo.50mg6660781652-57-1
AB120364NNC 711Potent, selective GAT-1 inhibitor10mg1610145645-62-1
AB120364NNC 711Potent, selective GAT-1 inhibitor50mg7160145645-62-1
AB120365CGP 57380MNK inhibitor1mg777522629-08-9
AB120365CGP 57380MNK inhibitor10mg1776522629-08-9
AB120365CGP 57380MNK inhibitor50mg7493522629-08-9
AB120368DR2313 (PARP Inhibitor XI)Potent, brain-penetrant and water-soluble PARP inhibitor1mg500284028-90-6
AB120368DR2313 (PARP Inhibitor XI)Potent, brain-penetrant and water-soluble PARP inhibitor10mg1388284028-90-6
AB120368DR2313 (PARP Inhibitor XI)Potent, brain-penetrant and water-soluble PARP inhibitor50mg5772284028-90-6
AB120369ZonisamideNon-selective Na+ / Ca2+channel blocker10mg99968291-97-4
AB120369ZonisamideNon-selective Na+ / Ca2+channel blocker50mg399668291-97-4
AB120370Ionomycin (free acid)Ca2+ ionophore1mg127756092-81-0
AB120370Ionomycin (free acid)Ca2+ ionophore5mg499556092-81-0
AB120371NS309Activates Ca2+-activated K+ channels10mg77718711-16-5
AB120371NS309Activates Ca2+-activated K+ channels50mg299718711-16-5
AB120374Ro 31-8220 mesylate (Bisindolylmaleimide IX)Protein kinase inhibitor1mg611125314-64-9
AB120374Ro 31-8220 mesylate (Bisindolylmaleimide IX)Protein kinase inhibitor10mg2109125314-64-9
AB120374Ro 31-8220 mesylate (Bisindolylmaleimide IX)Protein kinase inhibitor50mg7493125314-64-9
AB120375Okadaic acidPP1 and PP2A inhibitor25ug99978111-17-8
AB120375Okadaic acidPP1 and PP2A inhibitor100ug249878111-17-8
AB120377RottlerinKinase inhibitor10mg7771982-8-6
AB120377RottlerinKinase inhibitor50mg33861982-8-6
AB120378PK11195Peripheral benzodiazepine receptor antagonist10mg77785532-75-8
AB120378PK11195Peripheral benzodiazepine receptor antagonist50mg288685532-75-8
AB120379IberiotoxinSelective blocker of the high-conductance, Ca2+-activated K+ channel100ug2775129203-60-7
AB120380NGHVYEKLSSIE (Interfering peptide)Competes with AP-2 binding to NR2B1mg1277 
AB120381NGHVAEKLSSIE (Control Peptide)Control peptide for ab1203801mg1277 
AB120382Z-VAD-FMKIrreversible general caspase inhibitor1mg2109 
AB120382Z-VAD-FMKIrreversible general caspase inhibitor5mg7493 
AB120383UDP sodium salt (Uridine 5'-diphosphate)P2Y6 agonist. P2Y14 ligand.100mg61121931-53-3
AB120383UDP sodium salt (Uridine 5'-diphosphate)P2Y6 agonist. P2Y14 ligand.500mg249821931-53-3
AB120384UDP-glucoseHighly potent P2Y14 agonist1g249828053-08-9
AB120384UDP-glucoseHighly potent P2Y14 agonist100mg61128053-08-9
AB120385ATP disodium saltP2 receptor agonist. Signalling molecule.1g38934369-07-8
AB120385ATP disodium saltP2 receptor agonist. Signalling molecule.5g99934369-07-8
AB120385ATP disodium saltP2 receptor agonist. Signalling molecule.10g177634369-07-8
AB120385ATP disodium saltP2 receptor agonist. Signalling molecule.25g338634369-07-8
AB120386Sodium orthovanadate (for Decavanadate solution)Broad spectrum inhibitor of tyrosine phosphatases1g27813721-39-6
AB120386Sodium orthovanadate (for Decavanadate solution)Broad spectrum inhibitor of tyrosine phosphatases5g50013721-39-6
AB120387(+/-)-ClopidogrelPotent, selective P2Y12 antagonist10mg1388135046-48-9
AB120387(+/-)-ClopidogrelPotent, selective P2Y12 antagonist50mg5772135046-48-9
AB120388Topotecan hydrochloride (SK&F 104864)Topoisomerase inhibitor10mg500119413-54-6
AB120388Topotecan hydrochloride (SK&F 104864)Topoisomerase inhibitor50mg2109119413-54-6
AB120389Brilliant Blue GPotent, noncompetitive P2X7 antagonist1g17766104-58-1
AB120389Brilliant Blue GPotent, noncompetitive P2X7 antagonist100mg3896104-58-1
AB120390EquolMetabolite of phytoestrogen daidzein5mg99994105-90-5
AB120390EquolMetabolite of phytoestrogen daidzein25mg377494105-90-5
AB120391DaidzeinPhytoestrogen50mg888486-66-8
AB120392CyclopamineHh signaling inhibitor1mg16104449-51-8
AB120392CyclopamineHh signaling inhibitor5mg63834449-51-8
AB120393RisperidoneAtypical antipsychotic. 5HT2A / D2 antagonist.10mg999106266-06-2
AB120393RisperidoneAtypical antipsychotic. 5HT2A / D2 antagonist.50mg4107106266-06-2
AB120394Ziprasidone (CP 88059)Atypical antipsychotic. 5HT2A / D2 antagonist.10mg1277138982-67-9
AB120394Ziprasidone (CP 88059)Atypical antipsychotic. 5HT2A / D2 antagonist.50mg5384138982-67-9
AB120395GW791343P2X7 allosteric modulator10mg16101019779-04-4
AB120395GW791343P2X7 allosteric modulator50mg71601019779-04-4
AB120396DPCPXPotent A1 antagonist25mg611102146-07-6
AB120396DPCPXPotent A1 antagonist100mg1277102146-07-6
AB120397MRS 1754Selective A2B antagonist10mg1776264622-58-4
AB120397MRS 1754Selective A2B antagonist50mg7493264622-58-4
AB120398N6-Cyclopentyladenosine (CPA)Potent, selective A1 agonist25mg50041552-82-3
AB120398N6-Cyclopentyladenosine (CPA)Potent, selective A1 agonist100mg188741552-82-3
AB120400LY 341495 sodium saltWater-soluble, potent, selective group II antagonist. Group III antagonist at higher concentrations.1mg999 
AB120400LY 341495 sodium saltWater-soluble, potent, selective group II antagonist. Group III antagonist at higher concentrations.50mg11045 
AB120403beta-Nicotinamide adenine dinucleotide (beta-NAD)Coenzyme and enzyme substrate. P2Y11 agonist.1g349753-84-9
AB120403beta-Nicotinamide adenine dinucleotide (beta-NAD)Coenzyme and enzyme substrate. P2Y11 agonist.25mg38953-84-9
AB120403beta-Nicotinamide adenine dinucleotide (beta-NAD)Coenzyme and enzyme substrate. P2Y11 agonist.250mg127753-84-9
AB120404AM630 (Iodopravadoline)CB2 antagonist / inverse agonist10mg1776164178-33-0
AB120404AM630 (Iodopravadoline)CB2 antagonist / inverse agonist50mg7770164178-33-0
AB120405O-1918Antagonist of the non-CB1 vascular cannabinoid receptor10mg1776536697-79-7
AB120405O-1918Antagonist of the non-CB1 vascular cannabinoid receptor50mg6993536697-79-7
AB120407O-1602Potent, selective GPR55 agonist10mg1776317321-41-8
AB120407O-1602Potent, selective GPR55 agonist50mg6993317321-41-8
AB120408RuBi-GlutamateNovel caged-glutamate compound, uncaged by visible light10mg1887 
AB120409RuBi-GABANovel caged-GABA compound, uncaged by visible light10mg1887 
AB120410RuBi-4APCaged K+ channel blocker, uncaged by visible light10mg1887 
AB120411Endomorphin-1Highly potent and selective me agonist5mg999189388-22-5
AB120412Dynorphin APotent kappa agonist1mg188780448-90-4
AB120413A 438079Potent, competitive P2X7 receptor antagonist10mg1499899507-36-9
AB120413A 438079Potent, competitive P2X7 receptor antagonist50mg6383899507-36-9
AB120414MRS 2179Potent, selective P2Y1 antagonist10mg1887101204-49-3
AB120414MRS 2179Potent, selective P2Y1 antagonist50mg8381101204-49-3
AB120415NF 449Highly selective, potent P2X1 receptor antagonist10mg1776389142-38-5
AB120415NF 449Highly selective, potent P2X1 receptor antagonist50mg7493389142-38-5
AB120416Strychnine hydrochlorideGlycine antagonist100mg7771421-86-9
AB120417CTOPPotent, selective µ opioid receptor antagonist.1mg1499 
AB120419K252aHighly potent inhibitor of protein and CAM kinases1mg876999533-80-9
AB120419K252aHighly potent inhibitor of protein and CAM kinases200ug227699533-80-9
AB120420Buspirone hydrochloride5HT1A agonist. Anxiolytic.1g61133386-08-2
AB120420Buspirone hydrochloride5HT1A agonist. Anxiolytic.5g210933386-08-2
AB120421KN-62CaM kinase II inhibitor. P2X7 antagonist.1mg1277127191-97-3
AB120421KN-62CaM kinase II inhibitor. P2X7 antagonist.5mg2775127191-97-3
AB120422Suramin hexasodium saltNon-selective P2 purinergic antagonist100mg777129-46-4
AB120422Suramin hexasodium saltNon-selective P2 purinergic antagonist500mg3608129-46-4
AB120423KT5823Potent, selective inhibitor of PKG100ug1388126643-37-6
AB1204248-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP)Cell permeable cAMP analogue, protein kinase modulator20mg88893882-12-3
AB1204248-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP)Cell permeable cAMP analogue, protein kinase modulator100mg288693882-12-3
AB120425(+/-)-BlebbistatinPotent, selective, inhibitor of myosin II5mg1277674289-55-5
AB120425(+/-)-BlebbistatinPotent, selective, inhibitor of myosin II25mg4995674289-55-5
AB120428ZM 336372Potent, selective c-Raf inhibitor1mg389208260-29-1
AB120428ZM 336372Potent, selective c-Raf inhibitor10mg1776208260-29-1
AB120428ZM 336372Potent, selective c-Raf inhibitor50mg7493208260-29-1
AB120429Anandamide (in water soluble emulsion)Endogenous cannabinoid in water soluble emulsion10mg161094421-68-8
AB120429Anandamide (in water soluble emulsion)Endogenous cannabinoid in water soluble emulsion50mg699394421-68-8
AB120431Water soluble emulsion (blank)Water soluble emulsion. Negative control.1millilitres777 
AB120431Water soluble emulsion (blank)Water soluble emulsion. Negative control.10 millilitres2498 
AB120432Tertiapin QPotent inward rectifier K+ channel blocker1mg3608252198-49-5
AB120433Pep2mInhibitor of AMPA receptor trafficking2mg2886243843-42-7
AB1204342-Chloro-N6-cyclopentyladenosine (CCPA)Highly potent, selective A1 agonist10mg127737739-05-2
AB1204342-Chloro-N6-cyclopentyladenosine (CCPA)Highly potent, selective A1 agonist50mg510637739-05-2
AB120438IB-MECAHighly potent and selective A3 agonist5mg1887152918-18-8
AB120438IB-MECAHighly potent and selective A3 agonist25mg8159152918-18-8
AB120439SCH-58261Potent, highly selective A2A antagonist10mg1610160098-96-4
AB120439SCH-58261Potent, highly selective A2A antagonist50mg7160160098-96-4
AB120440NECAHighly potent adenosine agonist10mg50035920-39-9
AB120440NECAHighly potent adenosine agonist50mg149935920-39-9
AB1204428-(3-Chlorostyryl)caffeineSelective A2A receptor antagonist. MAO-B inhibitor.10mg777147700-11-6
AB1204428-(3-Chlorostyryl)caffeineSelective A2A receptor antagonist. MAO-B inhibitor.50mg3386147700-11-6
AB120445MRS 2211Selective competitve P2Y13 antagonist10mg888 
AB120445MRS 2211Selective competitve P2Y13 antagonist50mg4107 
AB120446Anandamide-d4 (ethanol solution)Internal standard for anandamide quantification1mg1887946524-40-9
AB120446Anandamide-d4 (ethanol solution)Internal standard for anandamide quantification5mg4995946524-40-9
AB120448(-)-CannabidiolCommon constituent of Cannabis10mg149913956-29-1
AB120448(-)-CannabidiolCommon constituent of Cannabis50mg599413956-29-1
AB120449BAPTA sodium saltSelective Ca2+ chelator1g1610126824-24-6
AB120449BAPTA sodium saltSelective Ca2+ chelator5g5661126824-24-6
AB120449BAPTA sodium saltSelective Ca2+ chelator250mg500126824-24-6
AB120450RuBi-nicotineNovel, caged nicotine compound, uncaged by visible light5mg1610 
AB120451DipyridamoleNon selective phosphodiesterase (PDE) inhibitor1g38958-32-2
AB120451DipyridamoleNon selective phosphodiesterase (PDE) inhibitor5g88858-32-2
AB120451DipyridamoleNon selective phosphodiesterase (PDE) inhibitor10g149958-32-2
AB120452IodotubercidinPotent, adenosine kinase inhibitor1mg111024386-93-4
AB120452IodotubercidinPotent, adenosine kinase inhibitor5mg360824386-93-4
AB120453CGS 21680Potent, selective A2A agonist10mg2387124182-57-6
AB120453CGS 21680Potent, selective A2A agonist50mg10268124182-57-6
AB120454NF023Competitive P2X1 receptor antagonist10mg1110104869-31-0
AB120454NF023Competitive P2X1 receptor antagonist50mg4607104869-31-0
AB120458HENECASelective A2A receptor agonist1mg999141018-30-6
AB120458HENECASelective A2A receptor agonist10mg2498141018-30-6
AB120459Mecamylamine hydrochlorideNon-competitive antagonist of nicotinic receptors10mg777826-39-1
AB120459Mecamylamine hydrochlorideNon-competitive antagonist of nicotinic receptors50mg3386826-39-1
AB120461Iminodyn-22™Potent, broad spectrum dynamin inhibitor5mg1998 
AB120462Iminodyn-17?Negative control for Iminodyn-22?5mg19981227697-48-4
AB120463Dynole-34-2?Potent dynamin I and dynamin II inhibitor5mg1998 
AB120464Dynole-31-2?Negative control for Dynole 34-2?5mg1998 
AB120465RTIL-13?Potent dynamin I and II inhibitor5mg19981009376-10-6
AB120466MiTMAB™Cell permeable dynamin I and dynamin II inhibitor5mg19981119-97-7
AB120467OcTMAB?Cell permeable dynamin I and dynamin II inhibitor5mg19981120-02-1
AB120469Acetylcholine chlorideEndogenous neurotransmitter active at acetylcholine receptors5g188760-31-1
AB120469Acetylcholine chlorideEndogenous neurotransmitter active at acetylcholine receptors50mg61160-31-1
AB120470BradykininBradykinin receptor agonist1mg2786846-3-3
AB120470BradykininBradykinin receptor agonist5mg5006846-3-3
AB120470BradykininBradykinin receptor agonist10mg7776846-3-3
AB120470BradykininBradykinin receptor agonist25mg14996846-3-3
AB120471Endothelin-1 (human, porcine)Vasoconstrictor peptide10ug611117399-94-7
AB120471Endothelin-1 (human, porcine)Vasoconstrictor peptide100ug1610117399-94-7
AB120471Endothelin-1 (human, porcine)Vasoconstrictor peptide500ug6383117399-94-7
AB120472N6-CyclohexyladenosineSelective A1 receptor agonist50mg77736396-99-3
AB120472N6-CyclohexyladenosineSelective A1 receptor agonist250mg299736396-99-3
AB120476Pro-Myristic AcidNegative control for MiTMAB? and OcTMAB?5mg199843016-78-0
AB120478Pifithrin-alpha-HBrp53 inhibitor10mg149963208-82-2
AB120478Pifithrin-alpha-HBrp53 inhibitor50mg599463208-82-2
AB120479Amyloid beta (1-40) (human)Amyloid beta protein fragment. Implicated in Alzheimerrsquos disease.1mg2997131438-79-4
AB120479Amyloid beta (1-40) (human)Amyloid beta protein fragment. Implicated in Alzheimerrsquos disease.5mg11877131438-79-4
AB120480Amyloid beta (25-35) (human)Highly toxic amyloid beta protein fragment1mg1610131602-53-4
AB120481Amyloid beta (42-1) (human)Inactive control for Amyloid beta (1-42) (ab120301) peptide1mg4496317366-82-8
AB120483Psalmotoxin-1Potent, selective ASIC1a blocker20ug611 
AB120483Psalmotoxin-1Potent, selective ASIC1a blocker100ug2498 
AB120484Tertiapin LQPotent, selective blocker of Kir1.1 channels. Tertiapin Q (ab120432) derivative.1mg1776 
AB120485LevcromakalimKATP channel activator.10mg199894535-50-9
AB120485LevcromakalimKATP channel activator.50mg865894535-50-9
AB120486CromakalimKIR6.x (KATP) channel activator10mg138894470-67-4
AB120486CromakalimKIR6.x (KATP) channel activator50mg588394470-67-4
AB120487Z-VAD(OMe)-FMKCell permeable, irreversible pan-caspase inhibitor1mg2109 
AB120487Z-VAD(OMe)-FMKCell permeable, irreversible pan-caspase inhibitor5mg5106 
AB120488Z-D(OMe)E(OMe)VD(OMe)-FMKCell permeable caspase-3 inhibitor1mg2609 
AB120488Z-D(OMe)E(OMe)VD(OMe)-FMKCell permeable caspase-3 inhibitor5mg10157 
AB120489Z-LE(OMe)VD(OMe)-FMKCell permeable derivative of caspase-4 inhibitor Z-LEVD-FMK1mg1499 
AB120489Z-LE(OMe)VD(OMe)-FMKCell permeable derivative of caspase-4 inhibitor Z-LEVD-FMK5mg5994 
AB120490GYKI 53655 hydrochlorideNon-competitive AMPA / kainate receptor antagonist10mg1887143692-48-2
AB120490GYKI 53655 hydrochlorideNon-competitive AMPA / kainate receptor antagonist50mg8159143692-48-2
AB120491(S)-(-)-BlebbistatinSelective myosin II ATPase activity inhibitor1mg888856925-71-8
AB120491(S)-(-)-BlebbistatinSelective myosin II ATPase activity inhibitor5mg2886856925-71-8
AB120492CGP 7930Positive GABAB receptor allosteric modulator10mg127757717-80-3
AB120492CGP 7930Positive GABAB receptor allosteric modulator50mg510657717-80-3
AB120493Adenosine 3',5'-cyclic monophosphate (cAMP)Second messenger. PKA activator.1g188760-92-4
AB120493Adenosine 3',5'-cyclic monophosphate (cAMP)Second messenger. PKA activator.5g699360-92-4
AB120493Adenosine 3',5'-cyclic monophosphate (cAMP)Second messenger. PKA activator.25g2131260-92-4
AB120494Nigericin Na+ saltK+ ionophore10mg149928643-80-3
AB120494Nigericin Na+ saltK+ ionophore50mg566128643-80-3
AB120495AnisomycinProtein synthesis inhibitor10mg77722862-76-6
AB120495AnisomycinProtein synthesis inhibitor50mg299722862-76-6
AB120497Bafilomycin A1Highly potent, selective (V)-ATPase inhibitor10ug111088899-55-2
AB120497Bafilomycin A1Highly potent, selective (V)-ATPase inhibitor100ug338688899-55-2
AB120498AdenosineEndogenous P1 receptor agonist1g27858-61-7
AB120498AdenosineEndogenous P1 receptor agonist5g50058-61-7
AB120498AdenosineEndogenous P1 receptor agonist25g77758-61-7
AB120499Monensin sodium saltNa+ ionophore1g88822373-78-0
AB120499Monensin sodium saltNa+ ionophore100mg27822373-78-0
AB120500Esomeprazole sodiumH+/ K+-ATPase (proton pump) inhibitor50mg500161796-78-7
AB120500Esomeprazole sodiumH+/ K+-ATPase (proton pump) inhibitor250mg2387161796-78-7
AB120501Leptomycin B (ethanol solution)Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export.5ug299787081-35-4
AB120501Leptomycin B (ethanol solution)Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export.25ug899187081-35-4
AB120502GW542573XNovel, selective KCa2 channel activator10mg1610660846-41-3
AB120502GW542573XNovel, selective KCa2 channel activator50mg7160660846-41-3
AB120503BAPTA-AMSelective Ca2+ chelator. Analogue of BAPTA.25mg1277126150-97-8
AB120504FlecainideSodium channel blocker10mg50054143-55-4
AB120504FlecainideSodium channel blocker50mg199854143-55-4
AB120505SimvastatinHMG-CoA reductase inhibitor50mg149979902-63-9
AB120505SimvastatinHMG-CoA reductase inhibitor250mg588379902-63-9
AB120506Cinnabarinic acidEndogenous mGlu4 selective agonist10mg1499606-59-7
AB120506Cinnabarinic acidEndogenous mGlu4 selective agonist50mg6383606-59-7
AB120507(R)-(+)-8-Hydroxy-DPAT hydrobromide (8-Hydroxy DPAT)Selective full 5-HT1A receptor agonist10mg149978095-19-9
AB120507(R)-(+)-8-Hydroxy-DPAT hydrobromide (8-Hydroxy DPAT)Selective full 5-HT1A receptor agonist50mg627278095-19-9
AB1205111-Phenylbiguanide5HT3 receptor agonist1g1499102-02-3
AB1205111-Phenylbiguanide5HT3 receptor agonist100mg500102-02-3
AB120514Sumatriptan succinate5-HT1 receptor agonist10mg777103628-48-4
AB120514Sumatriptan succinate5-HT1 receptor agonist50mg3386103628-48-4
AB120515L-694,247Highly potent 5-HT1D/5-HT1B receptor agonist10mg1776137403-12-4
AB120515L-694,247Highly potent 5-HT1D/5-HT1B receptor agonist50mg7493137403-12-4
AB120517BRL 15572 monohydrochlorideSelective 5-HT1D receptor antagonist10mg14991173022-77-9
AB120517BRL 15572 monohydrochlorideSelective 5-HT1D receptor antagonist50mg59941173022-77-9
AB120520BMY 7378 dihydrochloride5-HT1A partial agonist. alpha-adrenoceptor antagonist.10mg50021102-95-4
AB120520BMY 7378 dihydrochloride5-HT1A partial agonist. alpha-adrenoceptor antagonist.50mg199821102-95-4
AB120521Pindolol5-HT1A and 5-HT1B receptor antagonist1g99913523-86-9
AB120521Pindolol5-HT1A and 5-HT1B receptor antagonist250mg61113523-86-9
AB120522CP 94253 dihydrochlorideHighly potent, selective 5-HT1B agonist10mg1610131084-35-0
AB120522CP 94253 dihydrochlorideHighly potent, selective 5-HT1B agonist50mg6660131084-35-0
AB120523GR 127935 hydrochloridePotent, selective 5-HT1B/1D receptor antagonist10mg1998148642-42-6
AB120523GR 127935 hydrochloridePotent, selective 5-HT1B/1D receptor antagonist50mg8658148642-42-6
AB120524LY 310762 hydrochloridePotent, 5-HT1D antagonist10mg1499192927-92-7
AB120524LY 310762 hydrochloridePotent, 5-HT1D antagonist50mg6383192927-92-7
AB120526MetergolinePotent 5-HT receptor antagonist10mg50017692-51-2
AB120526MetergolinePotent 5-HT receptor antagonist50mg210917692-51-2
AB120528Serotonin hydrochloride (5-HT/5-Hydroxytryptamine)Endogenous neurotransmitter, 5HT receptor agonist1g5495153-98-0
AB120528Serotonin hydrochloride (5-HT/5-Hydroxytryptamine)Endogenous neurotransmitter, 5HT receptor agonist50mg500153-98-0
AB120528Serotonin hydrochloride (5-HT/5-Hydroxytryptamine)Endogenous neurotransmitter, 5HT receptor agonist250mg1887153-98-0
AB120529Sibutramine hydrochlorideSerotonin, noradrenaline & dopamine re-uptake inhibitor10mg61184485-00-7
AB120529Sibutramine hydrochlorideSerotonin, noradrenaline & dopamine re-uptake inhibitor50mg161084485-00-7
AB120530Methysergide maleate5-HT receptor antagonist10mg1776129-49-7
AB120530Methysergide maleate5-HT receptor antagonist50mg7770129-49-7
AB120531Nicardipine hydrochlorideL-type Ca2+ channel antagonist1g88854527-84-3
AB120531Nicardipine hydrochlorideL-type Ca2+ channel antagonist5g327554527-84-3
AB120532L-cis-DiltiazemSelective cyclic nucleotide-gated channel blocker5mg99942399-54-2
AB120532L-cis-DiltiazemSelective cyclic nucleotide-gated channel blocker25mg438542399-54-2
AB120534Bupropion hydrochlorideNon-selective DAT/NET inhibitor1g1276531677-93-7
AB120534Bupropion hydrochlorideNon-selective DAT/NET inhibitor50mg111031677-93-7
AB120534Bupropion hydrochlorideNon-selective DAT/NET inhibitor250mg410731677-93-7
AB120535Pancuronium dibromideCompetitive nicotinic acetylcholine receptor (nAChR) antagonist10mg50015500-66-0
AB120535Pancuronium dibromideCompetitive nicotinic acetylcholine receptor (nAChR) antagonist50mg177615500-66-0
AB120535Pancuronium dibromideCompetitive nicotinic acetylcholine receptor (nAChR) antagonist250mg599415500-66-0
AB120536Vecuronium bromideCompetitive nicotinic acetylcholine receptor (nAChR) antagonist10mg88850700-72-6
AB120536Vecuronium bromideCompetitive nicotinic acetylcholine receptor (nAChR) antagonist50mg149950700-72-6
AB120536Vecuronium bromideCompetitive nicotinic acetylcholine receptor (nAChR) antagonist250mg588350700-72-6
AB120537(-)-CytisinePotent, selective nAChR agonist10mg777485-35-8
AB120537(-)-CytisinePotent, selective nAChR agonist50mg2997485-35-8
AB120538Hexamethonium bromideAntagonist at a3-containing nAChR1g227655-97-0
AB120538Hexamethonium bromideAntagonist at a3-containing nAChR100mg38955-97-0
AB120540Quipazine dimaleate5-HT receptor agonist50mg777150323-78-7
AB120540Quipazine dimaleate5-HT receptor agonist250mg2997150323-78-7
AB120542alpha-BungarotoxinSubtype-selective alpha7 nAChR antagonist1mg149911032-79-4
AB120543NAN-190 hydrobromidePotent 5-HT1A antagonist50mg888115388-32-4
AB120543NAN-190 hydrobromidePotent 5-HT1A antagonist250mg3996115388-32-4
AB120544GR113808Potent, highly selective 5-HT4  antagonist10mg1277144625-51-4
AB120544GR113808Potent, highly selective 5-HT4  antagonist50mg5384144625-51-4
AB120546LY 272015 hydrochlorideHighly potent, selective 5-HT2B  antagonist10mg1887172895-15-7
AB120546LY 272015 hydrochlorideHighly potent, selective 5-HT2B  antagonist50mg8159172895-15-7
AB120548Cisapride5-HT4 receptor agonist. hERG blocker.10mg88881098-60-4
AB120548Cisapride5-HT4 receptor agonist. hERG blocker.50mg377481098-60-4
AB120549Spiperone hydrochloride5-HT and D2-like receptor antagonist50mg6112022-29-9
AB120549Spiperone hydrochloride5-HT and D2-like receptor antagonist250mg12772022-29-9
AB120550WAY-100635 maleatePotent, selective, silent 5-HT1A receptor antagonist10mg1277634908-75-1
AB120550WAY-100635 maleatePotent, selective, silent 5-HT1A receptor antagonist50mg4995634908-75-1
AB120552alpha-(Methylamino)isobutyric acidGlutamine transport inhibitor1g37742566-34-9
AB120552alpha-(Methylamino)isobutyric acidGlutamine transport inhibitor250mg12772566-34-9
AB120553S 24795Partial alpha7 nAChR agonist10mg1110304679-75-2
AB120553S 24795Partial alpha7 nAChR agonist50mg4884304679-75-2
AB120554HC-030031TRPA1 blocker, orally active10mg888349085-38-7
AB120554HC-030031TRPA1 blocker, orally active50mg3608349085-38-7
AB120555alpha-Methyl 5-hydroxytryptamine maleate5-HT2A/2C receptor agonist10mg777304-52-9
AB120555alpha-Methyl 5-hydroxytryptamine maleate5-HT2A/2C receptor agonist50mg2997304-52-9
AB120555alpha-Methyl 5-hydroxytryptamine maleate5-HT2A/2C receptor agonist100mg5661304-52-9
AB120556SB 206553 hydrochloridePotent, selective 5-HT2B and 5-HT2C receptor agonist10mg1887158942-04-2
AB120556SB 206553 hydrochloridePotent, selective 5-HT2B and 5-HT2C receptor agonist50mg9158158942-04-2
AB120557TC-2403 oxalatePotent alpha4beta2 nAChR selective agonist10mg1110252870-46-5
AB120557TC-2403 oxalatePotent alpha4beta2 nAChR selective agonist50mg4884252870-46-5
AB120558PNU 282987Selective a7 nAChR agonist10mg1388123464-89-1
AB120558PNU 282987Selective a7 nAChR agonist50mg4607123464-89-1
AB120559PNU 120596Positive allosteric modulator for the a7 nicotinic acetylcholine receptor10mg1499501925-31-1
AB120559PNU 120596Positive allosteric modulator for the a7 nicotinic acetylcholine receptor50mg6383501925-31-1
AB120560GTS-21 dihydrochloride (DMBX-A)alpha7 nicotinic acetylcholine receptor agonist10mg999156223-05-1
AB120560GTS-21 dihydrochloride (DMBX-A)alpha7 nicotinic acetylcholine receptor agonist50mg3774156223-05-1
AB120562(-)-Nicotine ditartratePotent nAChR agonist50mg50065-31-6
AB120563(S)-(-)-RacloprideD2 receptor antagonist10mg77784225-95-6
AB120563(S)-(-)-RacloprideD2 receptor antagonist50mg299784225-95-6
AB120564CabergolineD2-like receptor agonist10mg149981409-90-7
AB120564CabergolineD2-like receptor agonist50mg599481409-90-7
AB120565Dopamine hydrochlorideEndogenous neurotransmitter1g38962-31-7
AB120565Dopamine hydrochlorideEndogenous neurotransmitter5g88862-31-7
AB120566DomperidonePeripheral D2-like receptor antagonist50mg77757808-66-9
AB120566DomperidonePeripheral D2-like receptor antagonist500mg499557808-66-9
AB120567SB-277011-A dihydrochloridePotent, highly selective D3  antagonist5mg11101226917-67-4
AB120567SB-277011-A dihydrochloridePotent, highly selective D3  antagonist25mg43851226917-67-4
AB120568PD 168077 maleatePotent, selective D4 agonist10mg1499190383-31-4
AB120568PD 168077 maleatePotent, selective D4 agonist50mg5994190383-31-4
AB120569Pramipexole dihydrochlorideDopamine D2-like receptor agonist. D3-preferring.10mg611104632-25-9
AB120569Pramipexole dihydrochlorideDopamine D2-like receptor agonist. D3-preferring.50mg2498104632-25-9
AB120570U 99194 maleate (PNU 99194)Potent, selective D3 antagonist10mg1277234757-41-6
AB120570U 99194 maleate (PNU 99194)Potent, selective D3 antagonist50mg5106234757-41-6
AB120573L-DOPA(ab120565) precursor5g50059-92-7
AB120573L-DOPA(ab120565) precursor25g149959-92-7
AB120573L-DOPA(ab120565) precursor100g499559-92-7
AB120574Bromocriptine mesylatePotent, selective D2-like dopamine receptor agonist100mg161022260-51-1
AB120574Bromocriptine mesylatePotent, selective D2-like dopamine receptor agonist500mg338622260-51-1
AB120575Ropinirole hydrochlorideSelective D2-like receptor agonist10mg61191374-20-8
AB120575Ropinirole hydrochlorideSelective D2-like receptor agonist50mg277591374-20-8
AB120576Asenapine maleateMultiple receptor antagonist. Anti-psychotic agent.10mg61185650-56-2
AB120576Asenapine maleateMultiple receptor antagonist. Anti-psychotic agent.50mg249885650-56-2
AB120578(R,S)-SulpirideD2-like dopamine receptor antagonist100mg50015676-16-1
AB120579(S)-SulpirideD2-like dopamine antagonist. Active enantiomer.1g188723672-07-3
AB120579(S)-SulpirideD2-like dopamine antagonist. Active enantiomer.100mg61123672-07-3
AB120580Thioridazine hydrochlorideDopamine receptor antagonist100mg611130-61-0
AB120580Thioridazine hydrochlorideDopamine receptor antagonist500mg2276130-61-0
AB120581A-412997 dihydrochlorideHighly selective D4 agonist10mg1277630116-49-3
AB120581A-412997 dihydrochlorideHighly selective D4 agonist50mg4995630116-49-3
AB120583SB 216641 hydrochlorideSelective h5-HT1B antagonist10mg1887193611-67-5
AB120583SB 216641 hydrochlorideSelective h5-HT1B antagonist50mg8381193611-67-5
AB120585RS 127445 hydrochlorideSelective, potent 5-HT2B antagonist10mg1610199864-86-3
AB120585RS 127445 hydrochlorideSelective, potent 5-HT2B antagonist50mg7160199864-86-3
AB120586GR 466115-HT1B/1D agonist10mg1499185259-85-2
AB120586GR 466115-HT1B/1D agonist50mg6383185259-85-2
AB120587Nefazodone hydrochloridePotent 5-HT2A antagonist10mg111082752-99-6
AB120587Nefazodone hydrochloridePotent 5-HT2A antagonist50mg377482752-99-6
AB120589SB 271046 hydrochloridePotent, selective 5-HT6 antagonist10mg1776209481-24-3
AB120589SB 271046 hydrochloridePotent, selective 5-HT6 antagonist50mg7493209481-24-3
AB120590SB 699551 dihydrochlorideSelective 5-HT5A receptor antagonist10mg1887791789-61-2
AB120590SB 699551 dihydrochlorideSelective 5-HT5A receptor antagonist50mg8159791789-61-2
AB1205915-Methyltryptamine hydrochloride5-HT agonist250mg5001010-95-3
AB120592LY 344864 hydrochlorideSelective, potent 5-HT1F agonist10mg1887186544-26-3
AB120592LY 344864 hydrochlorideSelective, potent 5-HT1F agonist50mg7992186544-26-3
AB120593LP-44Highly potent, selective 5-HT7 agonist10mg1887824958-12-5
AB120593LP-44Highly potent, selective 5-HT7 agonist50mg7992824958-12-5
AB120594LP-12 hydrochloride5-HT7 agonist10mg17761185136-22-4
AB120594LP-12 hydrochloride5-HT7 agonist50mg76591185136-22-4
AB120595SB 204741Selective 5-HT2B receptor antagonist10mg1388152239-46-8
AB120595SB 204741Selective 5-HT2B receptor antagonist50mg5495152239-46-8
AB120596L-741,626Potent and selective D2 antagonist10mg111081226-60-0
AB120596L-741,626Potent and selective D2 antagonist50mg488481226-60-0
AB120597SCH 23390 hydrochlorideSelective D1-like dopamine receptor antagonist10mg1388125941-87-9
AB120597SCH 23390 hydrochlorideSelective D1-like dopamine receptor antagonist50mg5384125941-87-9
AB120598L-745870 trihydrochlorideHighly potent, selective brain penetrant D4 antagonist10mg1277866021-03-6
AB120598L-745870 trihydrochlorideHighly potent, selective brain penetrant D4 antagonist50mg5106866021-03-6
AB120601Rotigotine hydrochlorideDopamine receptor agonist10mg1110125572-93-2
AB120601Rotigotine hydrochlorideDopamine receptor agonist50mg4496125572-93-2
AB120602Eticlopride hydrochlorideSelective D2-like receptor antagonist10mg127797612-24-3
AB120602Eticlopride hydrochlorideSelective D2-like receptor antagonist50mg538497612-24-3
AB120603Salsolinol hydrochlorideEndogenously synthesised dopamine derivative100mg61170681-20-8
AB120604(R)-(-)-Deprenyl hydrochloride (Selegiline hydrochloride)MAO-B selective inhibitor1g161014611-52-0
AB120604(R)-(-)-Deprenyl hydrochloride (Selegiline hydrochloride)MAO-B selective inhibitor250mg61114611-52-0
AB120605Harmanebeta-Carboline. Imidazoline ligand. MAO inhibitor.100mg500486-84-0
AB120606Tranylcypromine hydrochloride (2-PCPA)Irreversible monoamine oxidase (MAO) inhibitor50mg3891986-47-6
AB120607GBR 12909 dihydrochlorideSelective dopamine transport inhibitor10mg77767469-78-7
AB120607GBR 12909 dihydrochlorideSelective dopamine transport inhibitor50mg299767469-78-7
AB120609ReserpineIrreversible vesicular monoamine transporter (VMAT2) antagonist1g111050-55-5
AB120609ReserpineIrreversible vesicular monoamine transporter (VMAT2) antagonist250mg38950-55-5
AB120611PD 168568 dihydrochloridePotent and selective D4 antagonist10mg1388210688-56-5
AB120611PD 168568 dihydrochloridePotent and selective D4 antagonist50mg6161210688-56-5
AB120613Flupenthixol dihydrochlorideNon-selective dopamine receptor antagonist50mg3892413-38-9
AB120614Lovastatin (Mevinolin)Potent HMG CoA reductase inhibitor10mg77775330-75-5
AB120614Lovastatin (Mevinolin)Potent HMG CoA reductase inhibitor50mg338675330-75-5
AB120615ApocyninSelective NADPH-oxidase inhibitor1g611498-02-2
AB1206162,3-Butanedione 2-monoxime (BDM)Non-selective myosin ATPase inhibitor500mg38957-71-6
AB120617PP3Negative control for the Src kinase inhibitor PP210mg18875334-30-5
AB120618Curcumin (Diferuloylmethane)Flavonoid. Lipooxygenase inhibitor.? Anti-oxidant, anti-inflammatory agent.50mg500458-37-7
AB120618Curcumin (Diferuloylmethane)Flavonoid. Lipooxygenase inhibitor.? Anti-oxidant, anti-inflammatory agent.250mg1887458-37-7
AB120619(R)-(+)-SKF38393 hydrochlorideSelective D1 partial agonist. Active enantiomer of (plusminus)-SKF-38393.5mg177681702-42-3
AB120620KetoconazolePotent cytochrome P450 inhibitor. Anti-fungal agent.100mg99965277-42-1
AB120621Diclofenac SodiumPotent cyclo-oxygenase inhibitor1g38915307-79-6
AB120622Ellagic acidSelective, casein kinase 2 (CK2) inhibitor50mg611476-66-4
AB120629Doxorubicin hydrochlorideTopoisomerase II inhibitor. Antibiotic with cytotoxic actions.10mg138825316-40-9
AB120629Doxorubicin hydrochlorideTopoisomerase II inhibitor. Antibiotic with cytotoxic actions.50mg577225316-40-9
AB120631AcyclovirInhibits viral DNA polymerase. Antiherpetic agent50mg77759277-89-3
AB120631AcyclovirInhibits viral DNA polymerase. Antiherpetic agent100mg138859277-89-3
AB120633DAPTgamma-secretase inhibitor10mg1776208255-80-5
AB120633DAPTgamma-secretase inhibitor50mg7493208255-80-5
AB120636AndrographolidePotent anti-inflammatory agent100mg3895508-58-7
AB120637KU-55933Potent, selective, competitive ATM kinase inhibitor10mg1776587871-26-9
AB120638SB 202190Highly selective, potent, cell permeable p38 MAP kinase inhibitor10mg1610152121-30-7
AB120638SB 202190Highly selective, potent, cell permeable p38 MAP kinase inhibitor50mg6660152121-30-7
AB120639PD 0325901PD 032590110mg2276 
AB120639PD 0325901PD 032590150mg9380 
AB120642SQ 22536Non-competitive adenylyl cyclase inhibitor10mg127717318-31-9
AB120642SQ 22536Non-competitive adenylyl cyclase inhibitor50mg538417318-31-9
AB120643TranilastAnti-inflammatory agent10mg111053902-12-8
AB120643TranilastAnti-inflammatory agent50mg477353902-12-8
AB120644Withaferin A from Withania somniferaNaturally occurring withanolide/steroidal lactone with anti-cancer properties1mg11665119-48-2
AB120645Edaravone (MCI-186)Free radical scavenger with neuroprotective effects50mg99989-25-8
AB120645Edaravone (MCI-186)Free radical scavenger with neuroprotective effects250mg349789-25-8
AB120647HonokiolAnti-inflammatory and chemotherapeutic agent10mg111035354-74-6
AB120647HonokiolAnti-inflammatory and chemotherapeutic agent25mg227635354-74-6
AB120648SB 328437Highly potent and selective CCR3 antagonist10mg1554247580-43-4
AB120648SB 328437Highly potent and selective CCR3 antagonist50mg7049247580-43-4
AB120649SC-560Highly selective COX-1 inhibitor100mg1443188817-13-2
AB120650Sulindac sulfideActive metabolite of Sulindac. COX-1/ 2 inhibitor.5mg61132004-67-4
AB120650Sulindac sulfideActive metabolite of Sulindac. COX-1/ 2 inhibitor.25mg249832004-67-4
AB120651Fluvastatin, Sodium SaltCompetitive HMG-CoA reductase inhibitor50mg99993957-55-2
AB1206532-MethoxyestradiolPotent antitumor and antiangiogenic agent10mg888362-07-2
AB1206532-MethoxyestradiolPotent antitumor and antiangiogenic agent50mg2886362-07-2
AB120654Betulinic acidAnticancer agent. TGR5 agonist.10mg611472-15-1
AB120654Betulinic acidAnticancer agent. TGR5 agonist.50mg2498472-15-1
AB120656Tamoxifen citrateEstrogen receptor antagonist and partial agonist1g277554965-24-1
AB120656Tamoxifen citrateEstrogen receptor antagonist and partial agonist100mg61154965-24-1
AB12065717beta-EstradiolSelective agonist of ER receptor1g149950-28-2
AB12065717beta-EstradiolSelective agonist of ER receptor100mg61150-28-2
AB120659Tobramycin, free baseRibosomal translation inhibitor100mg77732986-56-4
AB120659Tobramycin, free baseRibosomal translation inhibitor500mg288632986-56-4
AB120660RibavirinAnti-viral nucleoside10mg38936791-04-5
AB120660RibavirinAnti-viral nucleoside50mg111036791-04-5
AB120661Minocycline hydrochlorideAntibiotic. Demonstrates multiple effects.50mg77713614-98-7
AB120662LuteolinAntioxidant, anti-inflammatory, anti-cancer flavonoid10mg777491-70-3
AB120662LuteolinAntioxidant, anti-inflammatory, anti-cancer flavonoid50mg2997491-70-3
AB120663Colchicine from Colchicum autumnaleInhibitor of microtubule formation1g99964-86-8
AB120664Mycophenolic AcidImmunosuppressant. Inosine monophosphate dehydrogenase inhibitor.100mg99924280-93-1
AB120665GANT58Downstream Hh signaling inhibitor10mg149964048-12-0
AB120665GANT58Downstream Hh signaling inhibitor50mg649464048-12-0
AB120666CryptotanshinoneSTAT3 inhibitor with diverse biological activities10mg111035825-57-1
AB120666CryptotanshinoneSTAT3 inhibitor with diverse biological activities50mg488435825-57-1
AB120668URB 597Potent and selective FAAH inhibitor5mg888546141-08-6
AB120668URB 597Potent and selective FAAH inhibitor25mg2886546141-08-6
AB120669BRL 52537 hydrochlorideHighly selective, potent kappa-opioid agonist10mg1110112282-24-3
AB120669BRL 52537 hydrochlorideHighly selective, potent kappa-opioid agonist50mg4496112282-24-3
AB120673DADLEdelta-opioid peptide agonist1mg27863631-40-3
AB120673DADLEdelta-opioid peptide agonist5mg77763631-40-3
AB120674DAMGOPotent and selective me opioid receptor agonist1mg50078123-71-4
AB120674DAMGOPotent and selective me opioid receptor agonist5mg149978123-71-4
AB120675DPDPEPotent, selective delta opioid receptor agonist1mg99988373-73-3
AB120675DPDPEPotent, selective delta opioid receptor agonist5mg410788373-73-3
AB120676Endomorphin 2Potent, selective me opioid receptor agonist5mg999141801-26-5
AB120680CTAPPotent, selective me opioid antagonist1mg1277103429-32-9
AB120681Dynorphin BEndogenous opioid peptide. kappa opioid agonist.1mg188783335-41-5
AB120682Nociceptin (1-13) NH2Potent ORL1 agonist1mg888178064-02-3
AB120684SNC80Highly potent, selective delta opioid receptor agonist10mg1887156727-74-1
AB120684SNC80Highly potent, selective delta opioid receptor agonist50mg7770156727-74-1
120685Pits*?Novel, selective clathrin inhibitor5mg1998 
AB120686Pits*? - negative controlNegative control for clathrin inhibitor Pits*?5mg1998 
AB120687Pitstop 2™Novel, selective cell permeable clathrin inhibitor5mg1998 
AB120688Pitstop 2™ - negative controlNegative control for clathrin inhibitor Pitstop 2™5mg1998 
AB120689Dyngo-4a™Novel, highly potent dynamin inhibitor. Dynasore (ab120192) analogue.5mg1998 
AB120708[DAla2]Deltorphin IISelective delta opioid receptor agonist1mg777122752-16-3
AB120709CarvedilolPotent beta and alpha1-adrenoceptor antagonist50mg61172956-09-3
AB120709CarvedilolPotent beta and alpha1-adrenoceptor antagonist250mg288672956-09-3
AB120710Isoprenaline hydrochlorideNon selective beta-adrenoceptor agonist100mg77751-30-9
AB120711Metoprolol tartratebeta1-adrenergic receptor antagonist50mg61156392-17-7
AB120712Oxymetazoline hydrochloridealpha1A and partial alpha2A adrenoceptor agonist.100mg5002315-2-8
AB120713Loperamide hydrochlorideSelective me opioid receptor agonist1g77734552-83-5
AB120714Salbutamol hemisulfateNon-selective beta-adrenoceptor agonist50mg77751022-70-9
AB120714Salbutamol hemisulfateNon-selective beta-adrenoceptor agonist250mg111051022-70-9
AB120715Venlaine hydrochlorideSerotonin-noradrenaline reuptake inhibitor10mg94499300-78-4
AB120715Venlaine hydrochlorideSerotonin-noradrenaline reuptake inhibitor50mg399699300-78-4
AB120716(-)-Epigallocatechin GallatePotent anti-oxidant flavonoid1mg888989-51-5
AB120717L-(-)-Norepinephrine-(+)-bitartrate (Noradrenaline)Endogenous alpha adrenoceptor agonist1g1499108341-18-0
AB120717L-(-)-Norepinephrine-(+)-bitartrate (Noradrenaline)Endogenous alpha adrenoceptor agonist5g6161108341-18-0
AB120718AMD3100 octahydrochlorideHighly selective CXCR4 antagonist10mg1277155148-31-5
AB120719IndomethacinNon-selective COX inhibitor100mg77753-86-1
AB120720Triptolide from Tripterygium wilfordiiAnti-inflammatory agent with multiple biological activities1mg88838748-32-2
AB120720Triptolide from Tripterygium wilfordiiAnti-inflammatory agent with multiple biological activities10mg227638748-32-2
AB120721MyricetinPotent anti-neoplastic, anti-oxidant and anti-inflammatory agent5mg389529-44-2
AB120721MyricetinPotent anti-neoplastic, anti-oxidant and anti-inflammatory agent25mg1110529-44-2
AB120722PiceatannolSyk tyrosine kinase inhibitor10mg149910083-24-6
AB120722PiceatannolSyk tyrosine kinase inhibitor50mg488410083-24-6
AB120723BaicaleinFlavonoid. Lipoxygenase inhibitor.50mg777491-67-8
AB120724InosinePurine nucleoside. Adenosine metabolite.1g38958-63-9
AB120724InosinePurine nucleoside. Adenosine metabolite.100mg27858-63-9
AB120725PentoxifyllinePhosphodiesterase inhibitor. Cytokine inhibitor.1g2786493-5-6
AB120725PentoxifyllinePhosphodiesterase inhibitor. Cytokine inhibitor.5g5006493-5-6
AB120726ResveratrolAntioxidant polyphenol with a multitude of biological activities100mg888501-36-0
AB120726ResveratrolAntioxidant polyphenol with a multitude of biological activities500mg2997501-36-0
AB120727Deferoxamine MesylateIron chelator1g888138-14-7
AB120728trans-Retinoic AcidVitamin A metabolite. Stem cell differentiator.50mg389302-79-4
AB120728trans-Retinoic AcidVitamin A metabolite. Stem cell differentiator.500mg777302-79-4
AB120729(plusmn)-Chlorpheniramine maleatePotent H1 antagonist and SNRI100mg389113-92-8
AB120730Chlorpromazine hydrochlorideTypical antipsychotic. Non-selective receptor antagonist.1g27869-09-0
AB120730Chlorpromazine hydrochlorideTypical antipsychotic. Non-selective receptor antagonist.5g77769-09-0
AB120731CimetidinePrototypic H2 antagonist. I1 agonist.100mg50051481-61-9
AB120732Cyproheptadine hydrochloridePotent H1 and 5-HT2B antagonist. Non-selective receptor antagonist.50mg77741354-29-4
AB120732Cyproheptadine hydrochloridePotent H1 and 5-HT2B antagonist. Non-selective receptor antagonist.100mg127741354-29-4
AB120733Diphenhydramine hydrochloridePotent H1 antagonist1g999147-24-0
AB120733Diphenhydramine hydrochloridePotent H1 antagonist500mg611147-24-0
AB120734Histamine dihydrochlorideEndogenous histamine receptor agonist50mg50056-92-8
AB120734Histamine dihydrochlorideEndogenous histamine receptor agonist250mg177656-92-8
AB120735Mepyramine maleateSelective H1 inverse agonist100mg61159-33-6
AB120736OlanzapineNon-selective 5-HT, dopamine, histamine and muscarinic antagonist.10mg611132539-06-1
AB120736OlanzapineNon-selective 5-HT, dopamine, histamine and muscarinic antagonist.50mg2498132539-06-1
AB120737Quetiapine hemifumarateD2 and 5-HT2 antagonist. Antipsychotic.10mg611111974-72-2
AB120737Quetiapine hemifumarateD2 and 5-HT2 antagonist. Antipsychotic.50mg2387111974-72-2
AB120738Ranitidine hydrochlorideSelective H2 antagonist10mg27866357-35-5
AB120738Ranitidine hydrochlorideSelective H2 antagonist50mg55566357-35-5
AB120739Trifluoperazine dihydrochlorideCell permeable calmodulin antagonist1g389440-17-5
AB120740(±)-SKF38393 hydrochlorideD1-like dopamine receptor agonist100mg127762717-42-4
AB120741Nociceptin (1-7) (Orphanin FQ (1-7))Bioactive fragment of nociceptin. ORL1 (NOP) receptor agonist.1mg1887178249-42-8
AB120743DexamethasoneAnti-inflammatory glucocorticoid100mg6111950-2-2
AB120744ClotrimazoleNon-selective P450 cytochrome inhibitor50mg50023593-75-1
AB120745Valproic acid, sodium saltHistone deacetylase inhibitor100mg5001069-66-5
AB120746Sodium salicylateCell permeable anti-inflammatory agent5g50054-21-7
AB120747TroloxAntioxidant vitamin E derivative500mg555 
AB120748Ouabain octahydrateNa+/K+ ATPase inhibitor100mg61111018-89-6
AB120749Quinacrine dihydrochlorideNon-selective phospholipase A2 inhibitor100mg3891969-5-6
AB120750L-ArgininePrecursor to nitric oxide synthesis100mg50074-79-3
AB120751Thioflavin TFluorescent cell permeable amyloid binding benzothiazol salt500mg5552390-54-7
AB120752(R,S)-Atenololbeta1 adrenoceptor antagonist1g55529122-68-7
AB120753Clonidine hydrochloridealpha2 adrenoreceptor agonist100mg6114205-91-8
AB120754Doxazosin mesylateSelective alpha1-adrenoceptor antagonist50mg88877883-43-3
AB120755Milnacipran hydrochlorideSerotonin and noradrenalin reuptake inhibitor10mg888101152-94-7
AB120755Milnacipran hydrochlorideSerotonin and noradrenalin reuptake inhibitor50mg3497101152-94-7
AB120756Naftopidil hydrochloridealpha1 adrenergic receptor antagonist10mg50057149-07-2
AB120756Naftopidil hydrochloridealpha1 adrenergic receptor antagonist50mg149957149-07-2
AB120757Propranolol hydrochloridePotent beta-adrenoceptor antagonist100mg555318-98-9
AB120758(R)-Tomoxetine hydrochloridePotent, selective norepinephrine re-uptake inhibitor10mg138882248-59-7
AB120758(R)-Tomoxetine hydrochloridePotent, selective norepinephrine re-uptake inhibitor50mg616182248-59-7
AB120759Xylazine hydrochloridealpha2 adrenergic receptor agonist1g50023076-35-9
AB120760FamotidineSelective H2 antagonist1g99976824-35-6
AB120760FamotidineSelective H2 antagonist500mg55576824-35-6
AB120761(R)-(-)-Phenylephrine hydrochloridealpha1 adrenoceptor agonist100mg55561-76-7
AB120762RosiglitazoneSelective PPARgamma agonist10mg555122320-73-4
AB120762RosiglitazoneSelective PPARgamma agonist50mg2387122320-73-4
AB120763Donepezil hydrochlorideAcetylcholinesterase inhibitor10mg555120011-70-3
AB120763Donepezil hydrochlorideAcetylcholinesterase inhibitor50mg2109120011-70-3
AB120764AripiprazolePartial dopamine D2 agonist100mg1887129722-12-9
AB120764AripiprazolePartial dopamine D2 agonist500mg2276129722-12-9
AB120765Fexofenadine hydrochlorideSelective H1 receptor antagonist10mg944153439-40-8
AB120765Fexofenadine hydrochlorideSelective H1 receptor antagonist50mg3774153439-40-8
AB120766LoratidineH1 receptor antagonist10mg111079794-75-5
AB120766LoratidineH1 receptor antagonist50mg427479794-75-5
AB120767Dexmedetomidine hydrochloridePotent, highly selective alpha2 agonist10mg1610145108-58-3
AB120767Dexmedetomidine hydrochloridePotent, highly selective alpha2 agonist50mg6771145108-58-3
AB120768Dobutamine hydrochloridebeta1 and beta2 adrenoceptor agonist50mg188749745-95-1
AB120769Maprotiline hydrochlorideNoradrenaline reuptake inhibitor100mg55510347-81-6
AB120770Octopamine hydrochlorideFull beta3 agonist: invertebrate biogenic amine100mg555770-05-8
AB120772Tamsulosin hydrochloridePotent, selective alpha1A antagonist10mg2387106463-17-6
AB120772Tamsulosin hydrochloridePotent, selective alpha1A antagonist50mg6771106463-17-6
AB120773UK 14,304 tartrateSelective alpha2 adrenergic agonist10mg127759803-99-5
AB120773UK 14,304 tartrateSelective alpha2 adrenergic agonist50mg482959803-99-5
AB120775CPPGPotent group II/III metabotropic glutamate receptor antagonist10mg1499183364-82-1
AB120775CPPGPotent group II/III metabotropic glutamate receptor antagonist50mg6993183364-82-1
AB120778Amthamine dihydrobromideSelective H2 agonist10mg1277106463-17-6
AB120778Amthamine dihydrobromideSelective H2 agonist50mg6050106463-17-6
AB120782Ketotifen fumarateSelective, H1 antagonist100mg88834580-14-8
AB120783(plusminus)-Bisoprolol hemifumarateSelective beta1 antagonist10mg1499104344-23-2
AB120783(plusminus)-Bisoprolol hemifumarateSelective beta1 antagonist50mg6494104344-23-2
AB120784(S)-Timolol maleatePotent non-selective beta-adrenoceptor antagonist100mg88826921-17-5
AB120785Atipamezole hydrochlorideSelective alpha2 adrenergic receptor antagonist10mg1610104075-48-1
AB120785Atipamezole hydrochlorideSelective alpha2 adrenergic receptor antagonist50mg6771104075-48-1
AB120786Formoterol hemifumaratePotent long-acting beta2-adrenergic receptor antagonist10mg133243229-80-7
AB120786Formoterol hemifumaratePotent long-acting beta2-adrenergic receptor antagonist50mg538443229-80-7
AB120787Medetomidine hydrochlorideSelective alpha2 adrenoceptor agonist10mg116686347-15-1
AB120787Medetomidine hydrochlorideSelective alpha2 adrenoceptor agonist50mg482986347-15-1
AB120788Mianserin hydrochlorideMultiple receptor antagonist. Activity at 5-HT2, H1 and alpha2 receptors.50mg77721535-47-7
AB120789Moxonidine hydrochlorideI1 imidazoline receptor and alpha2 adrenergic agonist10mg133275536-04-8
AB120789Moxonidine hydrochlorideI1 imidazoline receptor and alpha2 adrenergic agonist50mg538475536-04-8
AB120790Nebivolol hydrochlorideSelective beta1 antagonist10mg1554152520-56-4
AB120790Nebivolol hydrochlorideSelective beta1 antagonist50mg6993152520-56-4
AB120793TMPyP4 tosylateomerase inhibitor. Binds and stabilizes DNA G-quadruplexes.50mg88836951-72-1
AB120794Pioglitazone hydrochlorideSelective PPAR-gamma agonist10mg611112529-15-4
AB120794Pioglitazone hydrochlorideSelective PPAR-gamma agonist50mg2276112529-15-4
AB120795Rhodadyn C10™Highly potent cell permeable dynamin I inhibitor5mg1998 
AB120796Rhodadyn B10™Negative control for Rhodadyn C10™5mg1998 
AB120797Mitomycin C (MMC)Anti-cancer and antibiotic agent2mg2781950-7-7
AB120797Mitomycin C (MMC)Anti-cancer and antibiotic agent10mg12771950-7-7
AB1208002-Furoyl-LIGRLO-amide (2Fly)Potent and selective PAR2 agonist1mg1110729589-58-6
AB120801TRAP-6PAR1 agonist5mg1887141136-83-6
AB120802SC-66Allosteric Akt inhibitor10mg888871361-88-5
AB120802SC-66Allosteric Akt inhibitor50mg3608871361-88-5
AB120803VU 0360223Potent mGlu5 antagonist10mg16101274859-33-4
AB120803VU 0360223Potent mGlu5 antagonist50mg67711274859-33-4
AB120804CalpeptinPotent, cell permeable calpain inhibitor10mg1332117591-20-5
AB120804CalpeptinPotent, cell permeable calpain inhibitor50mg6050117591-20-5
AB120810DAPTAPotent, selective CCR5 antagonist1mg944106362-34-9
AB120811BX 513 hydrochloridePotent and selective CCR1 antagonist10mg18871216540-18-9
AB120811BX 513 hydrochloridePotent and selective CCR1 antagonist50mg79921216540-18-9
AB120814ZK 756326Non-peptide CCR8 chemokine receptor agonist10mg1388874911-96-3
AB120814ZK 756326Non-peptide CCR8 chemokine receptor agonist50mg6050874911-96-3
AB120815JervineSmoothened inhibitor1mg1277469-59-0
AB120815JervineSmoothened inhibitor5mg4496469-59-0
AB120816ItraconazoleCytochrome p450 inhibitor50mg77784625-61-6
AB120816ItraconazoleCytochrome p450 inhibitor100mg127784625-61-6
AB120817[Gln11]-Amyloid beta Peptide (1-28)Homologous to Amyloid beta protein. Induces amnesia.1mg1832106686-61-7
AB120817[Gln11]-Amyloid beta Peptide (1-28)Homologous to Amyloid beta protein. Induces amnesia.500ug1110106686-61-7
AB120818LY 341495 disodium saltWater-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 (ab120199)1mg999106686-61-7
AB120818LY 341495 disodium saltWater-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 (ab120199)10mg2498106686-61-7
AB120818LY 341495 disodium saltWater-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 (ab120199)50mg11045106686-61-7
AB120819JK 184Potent Hedgehog signaling inhibitor10mg1554315703-52-7
AB120819JK 184Potent Hedgehog signaling inhibitor50mg7049315703-52-7
AB120820[Gln22]-Amyloid beta Peptide (1-40)Mutant amyloid beta (1-40) peptide1mg3441144410-00-4
AB120820[Gln22]-Amyloid beta Peptide (1-40)Mutant amyloid beta (1-40) peptide500ug2331144410-00-4
AB120821SB 297006Potent, selective CCR3 antagonist10mg161058816-69-6
AB120821SB 297006Potent, selective CCR3 antagonist50mg677158816-69-6
AB120825Amyloid beta peptide (16-22)Amyloidogenic peptide forming an antiparallel beta-sheet1mg1998 
AB120826GSK 4716Selective ERRbetagamma agonist10mg888101574-65-6
AB120826GSK 4716Selective ERRbetagamma agonist50mg3552101574-65-6
AB120827Hydroxychloroquine sulfateAnti-inflammatory and anti-malarial agent.5mg888747-36-4
AB120827Hydroxychloroquine sulfateAnti-inflammatory and anti-malarial agent.25mg3386747-36-4
AB120829CyPPAFirst selective SK channel activator10mg155473029-73-9
AB120829CyPPAFirst selective SK channel activator50mg704973029-73-9
AB120830Amyloid beta Peptide (10-20)Soluble amyloid beta peptide fragment1mg999152286-31-2
AB120831misartanSelective angiotensin II (AT1) antagonist10mg1388144701-48-4
AB120831misartanSelective angiotensin II (AT1) antagonist50mg5384144701-48-4
AB120832FenofibratePotent, selective PPAR-alpha agonist5g38949562-28-9
AB120833Clofibric acidPPARalpha agonist1g611882-09-7
AB120834Amyloid beta Peptide (1-11)Amyloidogenic peptide1mg1832190436-05-6
AB120835TCS JNK 5aSelective JNK2/3 inhibitor10mg1443312917-14-9
AB120835TCS JNK 5aSelective JNK2/3 inhibitor50mg6494312917-14-9
AB120838Amyloid beta Peptide (12-28)Toxic amyloid beta peptide fragment1mg1443107015-83-8
AB120838Amyloid beta Peptide (12-28)Toxic amyloid beta peptide fragment500ug888107015-83-8
AB1208425-Aza-2'-deoxycytidinePotent DNA methyltransferase inhibitor; epigenetic modifier10mg13882353-33-5
AB1208425-Aza-2'-deoxycytidinePotent DNA methyltransferase inhibitor; epigenetic modifier50mg53842353-33-5
AB120846Amyloid beta Peptide (1-28)Amyloidogenic peptide1mg3441109770-29-8
AB120846Amyloid beta Peptide (1-28)Amyloidogenic peptide500ug2331109770-29-8
AB120847Metformin hydrochlorideAMPK activator100mg6111115-70-4
AB120851Amyloid beta Peptide (1-38) (Abeta38)Toxic amyloid beta peptide fragment100ug2331131438-74-9
AB120852Valinomycin from Streptomyces fulvissimusK+ selective ionophore10mg5552001-95-8
AB120852Valinomycin from Streptomyces fulvissimusK+ selective ionophore50mg18872001-95-8
AB120853Lithium chlorideGSK-3beta inhibitor1g3337447-41-8
AB120853Lithium chlorideGSK-3beta inhibitor5g6117447-41-8
AB120860(+)-Abscisic acidPhytohormone; produced by a variety of cells in humans and animals1mg388521293-29-8
AB120862Caffeic acidSpecific NF-kappaB inhibitor1g500331-39-5
AB120862Caffeic acidSpecific NF-kappaB inhibitor250mg278331-39-5
AB120863Hydralazine hydrochlorideDNA methylation inhibitor. Anti-hypertensive agent1g389304-20-1
AB120865Procaine hydrochlorideNa+ channel blocker. DNA methylation inhibitor.250mg5551951-5-8
AB120866FFN102 (Mini 102)Exogenous fluorescent substrate5mg19981234064-11-9
AB120867FFN202 (Mini 202)Novel, pH responsive FFN. Enables pH measurement of synaptic or secretory vesicles.5mg19981234064-29-9
AB120870beta-AlanineEndogenous glycine agonist1g500107-95-9
AB120873Fura-2 AM (Fura-2 acetoxymethyl ester)Selective Ca2+ chelator; fluorescent indicator1mg1887108964-32-5
AB120948Sodium butyrateHistone deacetylase inhibitor1g1554156-54-7
AB120948Sodium butyrateHistone deacetylase inhibitor50mg389156-54-7
AB120948Sodium butyrateHistone deacetylase inhibitor250mg611156-54-7
AB120951NifuroxazideJAK/STAT signaling inhibitor. Nitrofuran antibiotic.100mg333965-52-6
AB120952StatticSelective STAT3 inhibitor10mg77719983-44-9
AB120952StatticSelective STAT3 inhibitor50mg288619983-44-9
AB120955Procainamide hydrochlorideSodium channel blocker. Specific DNA methyltransferase inhibitor 1.10g389614-39-1
AB120955Procainamide hydrochlorideSodium channel blocker. Specific DNA methyltransferase inhibitor 1.25g888614-39-1
AB120957Amyloid beta Peptide (1-40), (rat/mouse)Rat form of the amyloid beta (1-40) peptide1mg2553144409-98-3
AB120959Amyloid beta Peptide (1-42) (rat/mouse)Rat form of the amyloid beta (1-42) peptide500ug2553166090-74-0
AB120961PterostilbeneAntioxidant and anti-apoptotic agent; analog of resveratrol10mg1943537-42-8
AB120963Amyloid beta Peptide (1-43) (Abeta43)Highly toxic, amyloidogenic amyloid beta peptide fragment500ug4107134500-80-4
AB120964CrosstideAkt peptide substrate1mg999171783-05-4
AB120965Crosstide (biotinylated)Akt peptide substrate, biotinylated1mg1499 
AB120967CantharidinProtein phosphatases 1 and 2A (PP1, PP2A) inhibitor25mg55556-25-7
AB120967CantharidinProtein phosphatases 1 and 2A (PP1, PP2A) inhibitor100mg161056-25-7
AB120969Amyloid beta Peptide (22-35)Cytotoxic amyloid beta peptide fragment1mg2775144189-71-9
AB120974Amyloid beta Peptide (31-35)Amyloidogenic peptide1mg1499149385-65-9
AB120975Meropenem trihydrateBroad-spectum beta-lactam antibiotic10mg500119478-56-7
AB120975Meropenem trihydrateBroad-spectum beta-lactam antibiotic50mg2109119478-56-7
AB120977Amyloid beta Peptide (35-25)Inactive control for Amyloid beta (25-35)1mg3330147740-73-6
AB120979Ro 67-4853PAM for mGlu110mg1110302841-89-0
AB120979Ro 67-4853PAM for mGlu150mg4884302841-89-0
AB120986CardamoninAnti-cancer, anti-inflammatory spice-derived chalcone analog10mg144319309-14-9
AB120986CardamoninAnti-cancer, anti-inflammatory spice-derived chalcone analog50mg643819309-14-9
AB120990AcetaminophenSelective COX-3 inhibitor100mg888103-90-2
AB120992Amyloid beta Peptide (40-1)Inactive control for Amyloid beta (1-40) (ab120479) peptide500ug4940144409-99-4

 

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7